Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3019420	s-trypt	ug/l (ug/l)	2281	3486	0.06%
3019420	s-trypt	— (—)	325	364	100.00%	Distribution not available
3019420	s-tryptaasi	ug/l (ug/l)	264	314	0.00%
3019420	tryptaasi	ug/l (ug/l)	71	86	0.00%
3019420	s-trypt	µg/l (ug/l)	25	26	0.00%
3019420	s-trypt	ug/l______ (ug/l)	25	57	0.00%
3019420	s-tryptaasi	ug/l______ (ug/l)	20	36	0.00%	Distribution not available
3019420	s-trypt	UG/L (ug/l)	13	14	0.00%
3019420	tryptaasi	ug/l______ (ug/l)	7	10	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other and unspecified urticaria

649

447

15.48

307.65

1.4

1.6

5.85

7.72

ug/l

2.19

583

401

Other and unspecified effects of external causes

963

625

16.42

307.65

1.5

1.6

8.39

7.39

ug/l

0.43

847

581

Urticaria and erythema

923

841

11.46

307.65

1.4

1.5

6.51

7.97

ug/l

1.09

845

763

Adverse effects, not elsewhere classified

927

447

22.80

307.65

1.5

8.50

7.39

ug/l

0.44

813

415

Urticaria

874

714

12.89

307.65

1.4

1.6

6.08

7.67

ug/l

1.94

800

646

Allergic rhinitis

460

654

7.11

300.94

1.3

1.6

6.32

7.43

ug/l

0.73

427

604

Dermatitis and eczema

1066

1647

3.87

296.55

1.4

1.6

6.71

9.30

ug/l

2.99

987

1494

Diseases of the skin and subcutaneous tissue

770

735

5.30

283.44

1.4

1.8

7.49

10.06

ug/l

1.17

704

664

ILD medications: prednisolone, methylprednisolone, prednisone

995

1486

3.76

259.88

1.5

8.32

8.27

ug/l

0.02

909

1360

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

241

200

12.74

243.28

1.8

1.6

14.18

8.50

ug/l

0.82

216

173

Oral corticosteroids

968

1603

3.57

241.11

1.5

7.42

8.66

ug/l

0.76

883

1465

Pollen allergy

377

554

6.93

239.47

1.3

1.5

5.35

6.69

ug/l

1.87

347

500

Vasomotor and allergic rhinitis

492

955

5.12

230.21

1.4

1.5

6.55

7.37

ug/l

0.48

454

877

ILD medications

979

1543

3.45

224.81

1.5

8.39

8.13

ug/l

0.09

892

1411

Dermatitis

585

1382

4.19

214.49

1.6

7.51

9.57

ug/l

1.42

543

1259

Asthma (only as main-diagnosis)

674

883

4.31

209.60

1.4

1.6

6.46

8.23

ug/l

1.93

614

825

Asthma (only as main-diagnosis), excluding more controls

665

856

4.34

207.43

1.4

1.6

6.42

8.22

ug/l

1.94

605

801

Other and unspecified dermatitis

513

1164

4.46

205.65

1.6

7.58

9.85

ug/l

1.33

480

1059

First line medication for Crohn's disease

922

1515

3.30

198.58

1.5

8.84

8.03

ug/l

0.30

841

1383

Inflammatory bowel disease treatment related agents

960

1688

3.18

197.58

1.5

7.70

8.65

ug/l

0.53

875

1543

Asthma and allergy

205

185

11.22

191.96

1.5

6.74

6.60

ug/l

0.04

191

170

Asthma (mode)

675

891

4.02

187.94

1.4

1.6

6.78

8.19

ug/l

1.20

618

833

Examination and observation for other reasons

475

511

5.29

185.22

1.4

1.6

7.39

7.88

ug/l

0.19

443

449

Other and unspecified drugs and medicaments

202

194

10.95

185.07

1.7

1.5

13.99

8.55

ug/l

0.66

178

172

Asthma

661

883

3.90

175.85

1.4

1.6

6.75

8.23

ug/l

1.26

603

825

Allergic urticaria

180

158

11.92

175.02

1.4

1.5

5.15

7.06

ug/l

1.41

171

138

Oedema, not elsewhere classified

344

620

5.50

174.76

1.6

1.5

7.53

9.67

ug/l

0.73

308

567

Asthma, excluding more controls

650

856

3.94

174.72

1.4

1.6

6.80

8.22

ug/l

1.14

592

801

Atopic dermatitis

589

1290

3.68

169.68

1.3

1.6

5.59

8.31

ug/l

5.09

548

1157

Symptoms and signs involving the skin and subcutaneous tissue

653

1902

3.27

165.51

1.4

1.6

8.06

8.43

ug/l

0.13

614

1727

Asthma, hospital admissions , main diagnosis only

727

2061

3.10

164.54

1.5

7.46

8.51

ug/l

0.62

664

1888

Asthma (diagnoses ohter than nonallergic)

757

2053

3.00

159.63

1.5

7.79

8.40

ug/l

0.30

693

1877

Dermatographic urticaria

159

138

12.11

155.89

1.5

1.6

5.71

8.23

ug/l

0.84

148

121

Asthma and allergy, excluding more controls

205

247

8.40

155.06

1.5

6.74

6.40

ug/l

0.11

191

219

Other special examinations and investigations of persons without complaint or reported diagnosis

464

511

4.64

150.24

1.4

1.6

8.83

7.88

ug/l

0.22

430

449

Medical observation and evaluation for suspected diseases and conditions

459

511

4.63

148.95

1.7

1.6

7.89

7.88

ug/l

0.00

432

449

453

1184

3.84

148.30

1.6

1.5

8.08

8.42

ug/l

0.10

421

1073

Actinic keratosis

299

519

5.31

142.71

1.3

1.7

9.69

10.19

ug/l

0.07

289

469

Asthma, hospital admission 2, infections

519

1513

3.38

139.58

1.6

8.15

8.72

ug/l

0.19

481

1378

Asthma-related infections

519

1513

3.38

139.58

1.6

8.15

8.72

ug/l

0.19

481

1378

Allergic asthma (mode)

260

446

5.78

139.25

1.4

1.5

6.59

7.71

ug/l

0.38

240

409

Allergic asthma (mode), excluding more controls

260

446

5.78

139.22

1.4

1.5

6.59

7.68

ug/l

0.37

240

410

318

594

4.87

137.36

1.4

1.7

10.49

10.08

ug/l

0.06

308

532

Skin changes due to chronic exposure to nonionizing radiation

302

545

5.08

137.06

1.3

1.7

9.65

10.14

ug/l

0.07

292

493

Melanocytic naevi, other sites/unspecified

177

216

8.55

135.26

1.2

1.6

6.44

7.54

ug/l

0.47

170

191

Atopic dermatitis, strict definition with reimbursement

338

763

4.32

128.33

1.3

1.6

5.50

7.80

ug/l

2.82

310

680

Pain in joint

482

825

3.62

124.94

1.4

1.6

7.41

7.94

ug/l

0.24

445

751

Unspecified privation

181

252

7.42

123.34

1.6

1.5

11.04

8.84

ug/l

0.21

170

222

Headache

541

1342

3.14

121.76

1.5

7.16

8.30

ug/l

0.53

502

1226

Asthma, including avohilmo

865

1898

2.52

118.81

1.4

1.6

6.78

8.59

ug/l

1.92

789

1740

Desensitization to allergens

153

184

8.80

118.71

1.5

5.73

7.57

ug/l

0.79

142

163

Exposure to unspecified factor

782

2088

2.56

117.73

1.5

1.6

9.34

7.81

ug/l

0.56

676

1951

Complications of medical and surgical care

579

1847

2.84

113.77

1.7

1.5

11.41

7.85

ug/l

1.31

530

1692

Dermatitis due to ingested food

101

15.78

112.23

1.5

1.3

7.41

5.57

ug/l

0.37

Allergic contact dermatitis

179

274

6.69

111.52

1.3

1.6

5.53

8.81

ug/l

2.53

167

245

Asthma, unspecified (mode), excluding more controls

397

790

3.63

108.89

1.5

1.7

7.69

8.28

ug/l

0.25

363

740

Toxic effect of contact with venomous animals

111

11.92

107.16

1.5

5.66

6.91

ug/l

0.50

Chronic lower respiratory diseases

860

1886

2.42

106.50

1.5

1.6

7.98

8.24

ug/l

0.10

784

1727

Asthma, unspecified (mode)

398

817

3.54

105.98

1.5

1.7

7.77

8.28

ug/l

0.22

364

764

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

103

12.40

101.65

1.5

6.24

7.64

ug/l

0.44

Other disorders of white blood cells

113

115

10.30

99.40

1.5

1.8

8.83

8.72

ug/l

0.02

102

General symptoms and signs

719

1421

2.55

97.87

1.5

7.24

8.23

ug/l

0.64

653

1301

Other skin changes

202

395

5.20

97.36

1.2

1.7

7.83

11.22

ug/l

0.74

194

356

Other complications of surgical and medical care, not elsewhere classified

154

238

6.66

95.27

2.0

1.5

18.71

8.03

ug/l

1.16

144

208

Other soft tissue disorders, not elsewhere classified

672

1511

2.54

94.93

1.5

1.6

9.58

8.09

ug/l

0.47

613

1379

Asthma/COPD (KELA code 203)

689

1886

2.46

94.73

1.5

1.6

7.31

8.24

ug/l

0.54

635

1727

Melanocytic naevi

315

896

3.57

92.68

1.4

1.5

6.98

7.45

ug/l

0.21

298

813

Other disorders of skin and subcutaneous tissue

519

1646

2.68

90.30

1.4

1.6

8.91

8.68

ug/l

0.07

488

1499

Fever of other and unknown origin

405

1167

3.03

88.75

1.5

1.6

8.22

8.63

ug/l

0.13

373

1070

Other specific joint derangements/joint disorders

571

1372

2.61

87.20

1.5

7.66

7.67

ug/l

0.00

529

1245

Abnormalities of breathing

622

1434

2.50

84.73

1.4

1.6

8.69

7.92

ug/l

0.20

569

1316

Dermatitis due to substances taken internally

11.23

83.70

1.3

1.6

6.30

10.17

ug/l

0.74

General examination and investigation of persons without complaint and reported diagnosis

346

511

3.53

81.85

1.4

1.6

9.21

7.88

ug/l

0.45

324

449

Migraine

452

1291

2.75

80.82

1.5

6.30

7.47

ug/l

0.70

422

1169

Persons encountering health services for examination and investigation

353

511

3.48

80.71

1.5

1.6

10.29

7.88

ug/l

0.48

318

449

Atopic dermatitis, strict definition

320

979

3.24

80.55

1.3

1.5

5.49

6.90

ug/l

2.11

294

884

Obesity related asthma

283

828

3.46

79.72

1.6

8.90

8.57

ug/l

0.08

267

754

Other diseases of upper respiratory tract

665

1480

2.35

77.92

1.5

1.6

8.21

8.67

ug/l

0.17

594

1365

Pain in throat and chest

571

1378

2.47

76.83

1.5

8.74

7.72

ug/l

0.28

514

1265

Disturbances of skin sensation

257

745

3.49

73.56

1.5

7.12

7.62

ug/l

0.12

240

668

Biological medicines for asthma

12.33

71.48

1.3

1.5

6.06

6.42

ug/l

0.17

Low back pain

524

1471

2.42

70.17

1.5

7.85

7.58

ug/l

0.13

478

1338

Seborrhoeic keratosis

196

498

3.98

68.06

1.4

1.7

7.84

10.77

ug/l

0.79

187

439

Acute upper respiratory infections

662

1832

2.18

67.59

1.4

1.6

7.78

8.56

ug/l

0.38

614

1670

Dorsalgia

636

1513

2.24

67.12

1.5

9.21

7.59

ug/l

0.50

580

1375

ILD medications: immunosuppressive drugs

395

1383

2.60

66.18

1.5

1.6

7.86

8.18

ug/l

0.11

360

1262

Pain in limb

540

1476

2.34

66.13

1.4

1.6

10.10

8.09

ug/l

0.55

494

1349

Exposure to other specified factors

570

2223

2.21

65.93

1.5

6.92

8.55

ug/l

1.37

515

2038

Other pulmonary diagnosis

461

891

2.61

65.81

1.6

7.92

8.20

ug/l

0.11

412

833

Complications of surgical and medical care, not elsewhere classified

641

1996

2.15

65.52

1.7

1.5

10.87

7.65

ug/l

1.32

590

1826

Excluding asthma or asthma-COPD overlap

460

891

2.60

65.40

1.5

1.6

7.82

8.20

ug/l

0.15

413

833

Diseases of oesophagus, stomach and duodenum

677

1891

2.12

64.87

1.5

7.31

8.41

ug/l

0.83

627

1727

Malaise and fatigue

330

910

2.87

64.57

1.6

1.5

9.73

9.31

ug/l

0.08

304

836

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

336

1178

2.77

64.46

1.5

1.6

6.96

8.87

ug/l

1.12

291

1088

Supplementary factors related to causes of morbidity and mortality classified elsewhere

266

856

3.14

64.32

1.5

7.13

8.54

ug/l

0.64

244

777

Tramadol

509

1293

2.38

63.91

1.6

1.5

8.96

8.31

ug/l

0.19

473

1174

COPD differential diagnosis

455

891

2.57

63.38

1.5

1.6

7.83

8.19

ug/l

0.14

409

833

ILD differential diagnosis

455

891

2.57

63.37

1.5

1.6

7.83

8.19

ug/l

0.14

409

833

Lower back pain or/and sciatica

692

2086

2.07

63.04

1.5

8.10

8.35

ug/l

0.10

633

1910

Abnormalities of heart beat

257

792

3.17

62.89

1.5

8.01

8.21

ug/l

0.05

237

728

Symptoms and signs involving the circulatory and respiratory systems

627

1438

2.19

62.27

1.5

1.6

8.19

7.91

ug/l

0.07

567

1320

Other dorsopathies, not elsewhere classified

630

1522

2.16

60.84

1.5

8.37

7.57

ug/l

0.23

581

1382

Chronic rhinitis, nasopharyngitis and pharyngitis

240

752

3.22

60.64

1.4

1.5

6.87

7.65

ug/l

0.41

219

696

Sciatica+with lumbago

351

1182

2.65

60.58

1.5

8.82

7.82

ug/l

0.31

323

1075

Acute upper respiratory infections of multiple and unspecified sites

510

1649

2.27

60.44

1.5

1.6

7.96

8.46

ug/l

0.17

471

1499

Other headache syndromes

318

1172

2.73

59.62

1.7

1.6

7.35

8.22

ug/l

0.48

293

1073

Toxic effects of substances chiefly nonmedicinal as to source

137

294

4.76

59.48

1.6

1.5

5.91

7.85

ug/l

1.25

120

268

Cough

279

907

2.89

57.66

1.6

8.45

8.31

ug/l

0.03

256

832

Type of accident

243

798

3.08

56.83

1.4

1.6

7.27

8.75

ug/l

0.63

224

723

Chronic sinusitis

279

987

2.84

56.82

1.5

1.6

9.03

9.14

ug/l

0.02

251

914

Dyspnoea

559

1913

2.12

56.05

1.4

1.6

9.46

8.15

ug/l

0.35

513

1755

Pain, not elsewhere classified

209

632

3.34

56.03

1.5

8.69

9.33

ug/l

0.12

199

579

Pruritus

114

222

5.22

55.41

1.6

7.63

8.75

ug/l

0.34

100

195

Neurotic, stress-related and somatoform disorders

594

1987

2.07

55.40

1.4

1.6

7.68

8.18

ug/l

0.14

551

1807

Asthma-related pneumonia or sepsis

232

754

3.09

54.78

1.7

1.6

10.67

9.56

ug/l

0.19

211

686

Asthma, hospital admissions 3, pneumonia

232

754

3.09

54.78

1.7

1.6

10.67

9.56

ug/l

0.19

211

686

Migraine with aura

235

775

3.07

54.55

1.5

1.4

7.01

6.65

ug/l

0.10

224

693

Asthma-related pneumonia

231

751

3.09

54.52

1.7

1.6

10.67

9.59

ug/l

0.19

211

683

Undetermined asthma

114

225

5.13

54.44

1.5

10.62

7.68

ug/l

0.57

102

208

Anxiety disorders

594

1997

2.05

54.04

1.4

1.6

7.68

8.18

ug/l

0.14

551

1817

Undetermined asthma, excluding more controls

114

227

5.09

53.89

1.5

10.62

7.58

ug/l

0.60

102

210

Gastro-oesophageal reflux disease

428

1584

2.29

53.76

1.5

1.6

6.81

8.90

ug/l

1.86

399

1446

669

1698

2.00

53.17

1.4

1.5

9.06

7.95

ug/l

0.35

615

1550

Disorders of conjunctiva

567

2155

2.05

52.85

1.3

1.6

6.46

8.66

ug/l

2.47

531

1958

Other intervertebral disc disorders

489

1319

2.22

52.58

1.6

1.5

8.55

7.87

ug/l

0.28

459

1203

Conjunctivitis

530

2070

2.07

51.33

1.3

1.6

6.38

8.63

ug/l

2.40

497

1880

Other diseases of blood and blood-forming organs, wide

178

515

3.50

51.29

1.9

1.5

10.78

7.95

ug/l

1.00

162

469

Sequelae of external causes of morbidity and mortality

198

614

3.26

51.07

1.5

1.6

7.39

8.43

ug/l

0.50

179

557

Soft tissue disorders

607

1527

2.04

50.98

1.4

1.6

8.06

8.05

ug/l

0.00

551

1393

Liquid cancers

182

503

3.45

50.83

4.1

1.4

20.99

7.85

ug/l

4.57

174

449

Follow-up examination after treatment for conditions other than malignant neoplasms

218

447

3.26

50.51

1.5

1.6

6.86

7.73

ug/l

0.51

198

392

Bronchitis

666

2074

1.93

50.00

1.5

8.53

7.90

ug/l

0.18

611

1894

Anxiety disorders, excluding more controls

534

1651

2.08

49.47

1.4

1.6

7.99

8.30

ug/l

0.07

496

1502

Malignant neoplasm of skin, including Hilmo

303

769

2.65

49.19

1.4

10.34

8.11

ug/l

0.38

290

684

Immunodeficiencies

119

6.79

49.08

2.2

1.6

11.43

6.92

ug/l

0.51

104

Other diseases of intestines

660

1906

1.94

48.89

1.4

1.6

7.57

8.22

ug/l

0.31

606

1735

Myalgia

190

591

3.25

48.77

1.5

1.6

8.56

8.18

ug/l

0.06

178

539

Functional dyspepsia

206

674

3.09

48.56

1.7

1.5

9.52

9.03

ug/l

0.09

188

600

Opioids

590

1512

2.02

48.38

1.5

7.57

7.94

ug/l

0.15

543

1369

Somatoform disorder

153

417

3.72

48.30

1.4

1.5

6.73

7.49

ug/l

0.20

146

375

Other/unspecified dorsalgia

246

885

2.76

47.51

1.7

1.5

10.87

8.02

ug/l

0.42

238

802

Acute generalized exanthematous pustulosis

102

7.20

47.22

1.6

1.5

6.62

6.96

ug/l

0.10

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

402

1758

2.20

47.20

1.4

1.6

6.00

7.80

ug/l

3.07

374

1591

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

586

2028

1.96

46.72

1.7

1.5

9.53

7.92

ug/l

0.90

536

1864

GASTRO-related operations

468

1075

2.19

46.65

1.6

1.4

7.23

6.77

ug/l

0.26

422

981

Any gastric operation

468

1075

2.19

46.65

1.6

1.4

7.23

6.77

ug/l

0.26

422

981

Fibromyalgia

107

231

4.72

46.20

1.5

1.7

8.29

8.33

ug/l

0.01

101

208

Basal cell carcinoma, including Hilmo

258

632

2.78

45.89

1.3

10.39

7.27

ug/l

0.52

246

562

Codeine

553

1484

2.02

45.88

1.3

1.5

7.54

8.01

ug/l

0.17

511

1344

Allergic conjunctivitis

415

1876

2.14

45.39

1.4

1.6

6.02

7.86

ug/l

3.10

386

1701

Sequelae of other external causes

126

6.27

45.19

1.7

6.66

10.28

ug/l

0.99

111

Other external causes of accidental injury

449

1027

2.20

45.08

1.5

8.79

7.93

ug/l

0.18

402

966

Abdominal and pelvic pain

550

1369

2.02

44.93

1.5

7.60

7.66

ug/l

0.02

509

1259

Implicit viral Sepsis, including avohilmo

207

709

2.94

44.82

1.6

1.5

8.55

9.02

ug/l

0.10

196

647

Dorsopathies

593

1533

1.97

44.81

1.5

7.77

7.56

ug/l

0.06

544

1392

Acute sinusitis

352

1408

2.29

44.76

1.3

1.5

7.54

8.28

ug/l

0.27

322

1273

Chronic diseases of tonsils and adenoids

454

1354

2.12

44.57

1.5

1.6

7.68

7.82

ug/l

0.05

417

1248

Episodal and paroxysmal disorders

636

1700

1.90

43.91

1.5

1.6

7.90

7.92

ug/l

0.01

578

1550

Non-allergic asthma (mode), excluding more controls

124

308

4.02

43.88

1.7

1.5

8.49

7.38

ug/l

0.16

110

286

Anxiety (asthma-related co-morbidities)

431

1557

2.12

43.69

1.4

1.5

7.99

7.47

ug/l

0.11

395

1419

Other joint disorders

535

1391

2.01

43.53

1.5

7.82

7.65

ug/l

0.06

492

1261

Localized swelling, mass and lump of skin and subcutaneous tissue

209

736

2.86

43.24

1.4

1.6

10.71

9.51

ug/l

0.16

199

665

All anxiety disorders

440

1645

2.09

43.24

1.4

1.6

8.09

7.60

ug/l

0.10

403

1490

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

7.07

43.06

2.6

1.5

23.83

7.77

ug/l

0.64

Non-allergic asthma (mode)

124

313

3.96

42.93

1.7

1.5

8.49

7.42

ug/l

0.15

110

290

Complications of procedures, not elsewhere classified

477

1919

2.01

42.80

1.6

1.5

9.43

7.74

ug/l

0.85

439

1758

Malignant neoplasm of skin

275

724

2.58

42.63

1.4

10.67

7.59

ug/l

0.52

262

644

Accidents

441

1027

2.16

42.45

1.5

9.09

7.93

ug/l

0.25

395

966

Disorders of skin appendages

356

1619

2.20

42.07

1.3

1.5

6.66

8.37

ug/l

1.07

328

1471

Other condition

137

381

3.65

42.06

1.4

1.5

7.35

8.14

ug/l

0.35

127

338

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

597

2045

1.88

41.96

1.5

8.64

8.00

ug/l

0.18

552

1865

Liquid cancers, including Hilmo

200

609

2.91

41.58

3.9

1.4

20.50

7.67

ug/l

4.82

192

539

Migraine with aura and triptan purchases

168

536

3.18

41.53

1.3

1.4

5.24

6.71

ug/l

2.05

159

478

Irritable bowel syndrome

209

758

2.78

40.97

1.5

5.53

7.53

ug/l

2.84

194

690

Systemic connective tissue disorders

231

883

2.64

40.84

1.3

1.6

7.99

9.10

ug/l

0.23

208

805

Other disorders of lacrimal gland

248

984

2.54

40.61

1.6

1.5

9.49

8.29

ug/l

0.29

227

894

Basal cell carcinoma

239

606

2.70

40.55

1.3

10.45

7.33

ug/l

0.46

227

537

Other systemic involvement of connective tissue (FG)

180

593

3.01

40.49

1.4

1.5

8.63

8.03

ug/l

0.10

161

544

Suggestive for eosinophilic asthma

169

5.12

40.46

1.4

1.7

8.93

9.46

ug/l

0.07

152

Lumbar disc prolapse

369

1258

2.18

40.34

1.6

1.5

8.02

7.96

ug/l

0.02

347

1148

Shoulder lesions

405

1136

2.14

40.32

1.6

8.64

8.50

ug/l

0.04

380

1039

Intestinal infectious diseases, including avohilmo, including avohilmo

654

2012

1.82

40.05

1.5

1.6

9.01

8.06

ug/l

0.31

606

1832

Persons encountering health services for specific procedures and health care

644

2099

1.82

40.04

1.6

1.5

9.90

7.40

ug/l

0.93

594

1917

Recurrent or chronic depression

273

766

2.49

39.44

1.4

1.6

6.41

7.55

ug/l

1.52

249

700

Other anxiety disorders

349

1367

2.19

39.38

1.5

7.36

7.39

ug/l

0.01

322

1234

Nerve, nerve root and plexus disorders

600

1961

1.84

39.26

1.4

1.6

8.10

8.51

ug/l

0.16

558

1789

Chronic laryngitis and laryngotracheitis

107

265

4.09

38.72

1.3

1.6

5.98

8.37

ug/l

2.29

251

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

9.75

38.68

1.5

5.04

5.64

ug/l

0.34

Migraine without aura

187

660

2.86

38.65

1.5

1.4

5.51

6.70

ug/l

1.27

177

599

Diseases of the respiratory system

330

708

2.35

38.44

1.5

1.6

7.80

8.52

ug/l

0.28

291

661

Neurological diseases, wide definition

201

332

3.06

38.26

1.3

1.8

5.68

7.27

ug/l

2.03

180

303

Special screening examination for infectious and parasitic diseases

148

318

3.42

37.96

1.3

1.7

5.30

7.68

ug/l

2.71

140

273

COPD/asthma/ILD related infections

576

1546

1.87

37.83

1.4

1.5

6.87

7.77

ug/l

0.77

520

1417

COPD/asthma related infections

576

1546

1.87

37.83

1.4

1.5

6.87

7.77

ug/l

0.77

520

1417

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

430

1999

1.97

37.28

3.3

1.2

14.86

6.69

ug/l

5.44

405

1811

Cervicalgia

144

447

3.25

37.22

1.5

1.6

10.68

8.61

ug/l

0.24

131

402

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

343

1590

2.13

37.14

1.7

1.5

10.23

7.96

ug/l

0.90

316

1462

Disorders of lacrimal system

280

1203

2.30

36.95

1.6

9.25

8.43

ug/l

0.21

254

1100

Benign neoplasms

558

1635

1.86

36.91

1.5

9.70

7.59

ug/l

0.62

516

1476

Certain infectious and parasitic diseases

544

1450

1.89

36.51

1.5

8.62

7.54

ug/l

0.30

498

1311

Concussion

312

1089

2.23

36.45

1.5

1.7

8.15

8.28

ug/l

0.04

285

990

Cardiovascular diseases

438

1154

2.02

36.40

1.3

1.6

6.67

7.11

ug/l

0.20

396

1055

Other functional intestinal disorders

273

1072

2.33

36.32

1.5

1.6

7.40

8.89

ug/l

0.65

256

988

Nausea and vomiting

172

583

2.90

36.32

1.6

11.69

7.50

ug/l

0.44

160

527

Childhood asthma (age<16), excluding more controls

108

210

4.06

35.95

1.6

10.10

5.93

ug/l

0.56

187

External causes of morbidity and mortality

333

741

2.26

35.82

1.5

7.22

7.81

ug/l

0.30

293

697

Parasetamol

410

1006

2.07

35.64

1.5

9.74

6.72

ug/l

0.82

367

920

Childhood asthma (age<16)

108

213

4.00

35.30

1.6

10.10

5.97

ug/l

0.55

189

Injury, poisoning and certain other consequences of external causes

272

555

2.47

35.29

1.5

8.35

7.61

ug/l

0.24

239

527

Codeine or tramadol medication

634

1958

1.76

35.20

1.4

1.5

7.78

8.31

ug/l

0.22

585

1784

Implicit viral Sepsis

143

458

3.15

35.12

1.5

9.12

9.89

ug/l

0.12

136

414

Viral Sepsis

143

459

3.14

34.99

1.5

9.12

9.87

ug/l

0.11

136

415

Certain disorders involving the immune mechanism

148

486

3.08

34.88

1.8

1.5

10.85

7.86

ug/l

0.59

137

442

Symptoms and signs involving the digestive system and abdomen

514

1369

1.89

34.65

1.5

8.61

7.66

ug/l

0.25

478

1259

Spondylosis

275

938

2.30

34.64

1.6

12.46

8.70

ug/l

0.57

251

858

Other systemic involvement of connective tissue

183

677

2.73

34.63

1.3

1.6

8.60

9.47

ug/l

0.13

164

616

Arthropathies

517

1395

1.88

34.47

1.4

1.5

8.17

7.65

ug/l

0.12

470

1265

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

535

2321

1.80

34.34

1.6

1.5

8.05

8.26

ug/l

0.08

494

2120

Melanocytic naevi of trunk

112

313

3.63

34.24

1.5

7.79

8.38

ug/l

0.10

107

278

Disorders of eyelid, lacrimal system and orbit

489

1938

1.86

34.17

1.6

1.5

10.58

8.07

ug/l

0.70

446

1778

Intestinal infectious diseases

549

2292

1.79

34.05

1.6

1.5

9.66

7.86

ug/l

0.54

512

2089

Syncope and collapse

228

777

2.46

33.85

1.5

1.6

8.47

9.25

ug/l

0.19

209

717

Diarrhoea and gastroenteritis of presumed infectious origin

420

1970

1.91

33.35

1.6

1.5

9.92

7.99

ug/l

0.44

397

1793

Rotator cuff syndrome

314

1002

2.17

33.31

1.7

9.16

8.88

ug/l

0.08

296

917

Hypermobility syndrome

167

4.73

33.26

1.4

1.5

4.90

7.01

ug/l

1.49

148

Congenital malformations, deformations and chromosomal abnormalities

390

1914

1.94

32.74

3.4

1.2

15.51

6.46

ug/l

5.73

367

1737

Anaemias

161

344

3.02

32.70

1.6

1.4

9.39

7.04

ug/l

0.61

147

311

Depression

556

2109

1.77

32.65

1.5

1.6

7.32

8.43

ug/l

0.76

511

1922

Pain (limb, back, neck, head abdominally)

354

844

2.11

32.35

1.5

1.6

9.77

7.84

ug/l

0.37

320

769

Mycoses

191

749

2.57

32.21

1.5

7.69

7.75

ug/l

0.02

175

675

Conjunctivitis (acute, non atopic), including avohilmo

549

1874

1.77

31.93

1.4

1.6

6.66

8.97

ug/l

2.15

508

1710

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

234

655

2.42

31.91

1.3

1.4

10.73

7.59

ug/l

0.45

222

581

Any reimbursement code in KELA

370

904

2.06

31.84

1.4

1.6

6.42

7.39

ug/l

0.72

328

833

Cervical disc disorders

190

749

2.55

31.65

1.2

1.7

8.39

8.70

ug/l

0.05

179

685

Rash and other nonspecific skin eruption

199

4.23

31.48

1.7

1.6

7.17

9.06

ug/l

0.73

176

Neurological diseases

472

1269

1.87

31.23

1.5

1.6

6.91

8.01

ug/l

1.00

427

1148

Pain and other conditions associated with female genital organs and menstrual cycle

179

568

2.66

31.01

1.4

5.50

6.27

ug/l

0.87

167

507

Dysphagia

142

487

2.94

31.00

1.4

1.6

9.86

8.78

ug/l

0.15

132

440

Mood disorders, excluding more controls

519

1708

1.79

31.00

1.4

1.6

7.58

8.36

ug/l

0.49

476

1554

Certain infectious and parasitic diseases, including avohilmo

374

927

2.03

30.95

1.5

1.6

8.26

7.90

ug/l

0.15

337

841

Rheumatism, unspecified

273

3.67

30.88

1.7

8.59

8.64

ug/l

0.01

247

Finngen Rheumatological endpoints

540

1740

1.77

30.57

1.5

9.19

7.84

ug/l

0.36

495

1591

Injuries to the ankle and foot

452

2131

1.82

30.55

1.4

1.6

8.95

7.88

ug/l

0.34

412

1940

Seborrhoeic dermatitis

159

4.58

30.31

1.4

1.7

6.43

11.00

ug/l

1.74

142

Other general symptoms and signs

113

5.36

30.04

1.5

1.9

6.65

7.68

ug/l

0.23

103

Osteopathies and chondropathies

320

1457

2.02

29.87

1.9

1.5

11.84

8.15

ug/l

1.30

292

1342

Other malignant neoplasms of skin (=non-melanoma skin cancer)

220

622

2.41

29.83

1.3

10.88

7.32

ug/l

0.49

208

553

Mood disorders

571

2140

1.71

29.70

1.4

1.6

7.35

8.43

ug/l

0.75

524

1950

Spondylopathies

377

1143

1.96

29.56

1.5

11.81

8.11

ug/l

0.79

348

1038

Enlarged lymph nodes

105

311

3.41

29.37

1.5

6.73

8.07

ug/l

0.63

282

Intracranial trauma

331

1110

2.02

29.33

1.6

8.61

8.22

ug/l

0.12

304

1010

Migraine without aura and triptan purchases

152

559

2.75

29.25

1.5

1.4

5.24

6.64

ug/l

1.93

143

498

Neoplasms

450

1277

1.86

29.25

1.7

1.4

8.40

6.54

ug/l

1.17

413

1143

Mood [affective] disorders

568

2140

1.70

29.19

1.4

1.6

7.31

8.43

ug/l

0.78

521

1951

Other reaction to severe stress, and adjustment disorders

256

1192

2.16

29.10

1.4

1.5

7.22

7.56

ug/l

0.12

239

1080

Other noninfective gastroenteritis and colitis

171

668

2.58

29.07

1.7

1.5

7.83

8.93

ug/l

0.24

163

604

Vocal cord dysfunction

102

257

3.52

29.05

1.7

1.5

7.34

7.51

ug/l

0.05

237

Antihypertensive medication - note that there are other indications

411

1134

1.90

28.74

1.4

1.5

6.43

7.42

ug/l

0.56

373

1033

Dizziness and giddiness

413

1752

1.84

28.56

1.5

7.98

8.70

ug/l

0.25

378

1605

Rosacea

109

339

3.26

28.27

1.3

1.6

5.96

8.26

ug/l

1.60

102

304

Diseases of the musculoskeletal system and connective tissue

295

692

2.15

28.24

1.5

1.6

6.93

7.03

ug/l

0.04

261

622

Nasal polyp

110

345

3.21

28.08

1.4

1.5

8.70

10.18

ug/l

0.21

326

Sleep disorders (combined)

583

1803

1.69

27.98

1.5

1.6

6.96

8.62

ug/l

1.71

529

1656

Infections of the skin and subcutaneous tissue

349

1812

1.90

27.94

1.4

1.5

8.95

8.15

ug/l

0.22

309

1664

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

190

366

2.62

27.80

1.5

1.7

7.53

7.28

ug/l

0.07

170

327

Symptoms and signs involving the nervous and musculoskeletal systems

320

1654

1.94

27.34

1.5

9.33

8.55

ug/l

0.20

295

1512

Enthesopathies of lower limb, excluding foot

143

530

2.72

27.09

1.5

1.6

13.85

8.09

ug/l

0.50

131

478

Cervicobrachial syndrome

139

508

2.76

27.05

1.5

1.6

6.59

8.11

ug/l

0.66

133

462

Noninfective enteritis and colitis

275

1358

2.03

26.73

1.7

1.5

8.51

8.38

ug/l

0.03

257

1237

Symptoms and signs involving cognition, perception, emotional state and behaviour

523

2067

1.70

26.64

1.5

7.73

8.33

ug/l

0.26

482

1890

Implicit Sepsis

388

1559

1.84

26.60

1.5

9.15

8.56

ug/l

0.17

355

1430

Persons encountering health services for other counselling and medical advice, not elsewhere classified

579

1849

1.67

26.43

1.4

1.6

7.99

8.45

ug/l

0.18

535

1692

Viral infections characterized by skin and mucous membrane lesions

253

1220

2.08

26.29

1.9

1.6

8.84

8.54

ug/l

0.06

240

1109

Gastrointestinal diseases

333

844

1.98

26.10

1.5

1.6

6.84

7.32

ug/l

0.24

299

770

Soft tissue disorders related to use, overuse and pressure

149

576

2.60

25.96

1.5

1.7

6.61

9.08

ug/l

1.53

138

533

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

312

1624

1.92

25.96

1.6

1.5

10.16

8.45

ug/l

0.51

287

1487

Cardiovascular diseases (excluding rheumatic etc)

418

1328

1.81

25.66

1.4

1.5

7.22

6.94

ug/l

0.12

380

1208

Depression medications

189

380

2.51

25.65

1.4

7.01

6.88

ug/l

0.03

168

340

Acute bronchitis

230

1060

2.14

25.55

1.6

9.25

8.57

ug/l

0.13

210

966

Candidiasis, including avohilmo

204

916

2.24

25.54

1.5

8.27

7.43

ug/l

0.26

188

823

Visual disturbances and blindness

291

1491

1.96

25.52

1.4

1.5

8.85

8.70

ug/l

0.03

272

1361

Sleep apnoea

488

1804

1.71

25.37

1.6

8.66

8.84

ug/l

0.06

442

1659

Mycoses, including avohilmo

511

2335

1.67

25.29

1.5

8.09

8.26

ug/l

0.06

471

2133

Disorders of synovium and tendon

283

1211

1.99

25.25

1.3

1.6

7.57

8.30

ug/l

0.20

259

1107

Persons encountering health services in other circumstances, wide

589

1850

1.64

25.09

1.4

1.6

7.78

8.45

ug/l

0.30

536

1693

Infective dermatitis

180

3.98

25.03

1.6

1.7

7.38

10.81

ug/l

1.09

159

Sleep apnoea, including avohilmo

522

1888

1.68

25.02

1.6

8.59

8.72

ug/l

0.04

473

1737

Other heart diseases, wide

513

1849

1.68

25.01

1.7

1.5

9.06

7.18

ug/l

1.19

465

1706

Triptan medication for migraine, single purchase ok

452

1774

1.73

24.94

1.4

1.6

7.20

7.73

ug/l

0.20

416

1606

Migraine, single triptan purchase ok & required. ICD-code if available is included

452

1774

1.73

24.94

1.4

1.6

7.20

7.73

ug/l

0.20

416

1606

Temporomandibular joint disorders, including avohilmo

313

1607

1.90

24.77

1.4

1.5

6.36

7.40

ug/l

0.87

285

1453

Disorders of other endocrine glands

261

1282

2.01

24.71

1.8

1.5

9.54

8.04

ug/l

0.41

238

1169

Other nutritional deficiencies

397

2064

1.76

24.62

1.4

1.5

6.82

8.52

ug/l

1.74

364

1879

Other arthrosis

246

784

2.11

24.48

1.5

1.7

7.63

9.12

ug/l

0.62

228

717

Persons encountering health services in other circumstances

238

1151

2.06

23.91

1.4

1.5

7.07

8.64

ug/l

0.57

203

1047

Visual disturbances

276

1423

1.95

23.90

1.4

1.5

8.89

8.68

ug/l

0.04

257

1300

Hypothyroidism and >3 levothyroxin purchases

162

355

2.57

23.84

1.5

8.73

7.02

ug/l

0.31

148

319

Hypothyroidism, levothyroxine purchases

162

355

2.57

23.84

1.5

8.73

7.02

ug/l

0.31

148

319

Other acute lower respiratory infections

295

1480

1.91

23.72

1.6

1.5

9.67

8.11

ug/l

0.37

270

1348

All influenza

152

624

2.45

23.39

1.7

1.6

14.71

8.07

ug/l

0.60

138

572

Factors influencing health status and contact with health services

115

183

3.17

23.37

1.3

1.7

7.80

9.35

ug/l

0.31

167

Triptan medication for migraine, min. 3 purchases

378

1595

1.78

23.34

1.4

1.5

6.23

7.50

ug/l

0.99

347

1445

Diseases of salivary glands

202

938

2.17

23.32

1.4

1.5

6.77

7.70

ug/l

0.45

189

849

Depression or dysthymia

336

977

1.88

23.30

1.5

1.6

8.14

8.33

ug/l

0.07

308

898

D07AA Corticosteroids, weak (group I)

124

462

2.71

23.29

1.4

1.5

6.04

7.06

ug/l

0.75

108

420

Other enthesopathies

164

699

2.36

23.21

1.2

1.7

6.92

8.52

ug/l

0.56

150

636

Other medical care

251

1051

2.01

23.12

1.7

1.5

11.83

7.82

ug/l

1.00

234

963

Acute pharyngitis

113

400

2.82

22.97

1.6

6.24

7.26

ug/l

0.42

101

357

Subjective visual disturbances

165

713

2.33

22.69

1.4

1.5

6.74

7.83

ug/l

0.62

154

641

Implicit Sepsis, including avohilmo

420

1755

1.71

22.69

1.5

9.10

8.33

ug/l

0.25

387

1608

Autoimmune diseases related-to ILD

454

2285

1.66

22.56

1.4

1.5

6.99

8.34

ug/l

1.06

414

2094

Hypothyroidism (congenital or acquired)

159

356

2.51

22.40

1.5

8.78

7.01

ug/l

0.32

147

320

Other benign neoplasms of skin

197

926

2.14

22.06

1.5

11.46

8.18

ug/l

0.39

189

835

Deviated nasal septum

156

665

2.36

22.04

1.5

1.6

6.36

9.32

ug/l

1.53

134

627

Behavioural syndromes associated with physiological disturbances and physical factors

508

2127

1.62

21.93

1.4

1.6

6.62

8.81

ug/l

2.51

470

1946

Other antidepressants

518

1620

1.64

21.91

1.5

1.6

8.19

8.92

ug/l

0.27

471

1485

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

445

1546

1.69

21.78

1.7

1.5

10.53

7.77

ug/l

1.07

400

1417

445

1546

1.69

21.78

1.7

1.5

10.53

7.77

ug/l

1.07

400

1417

Cardiac arrhythmias

359

1295

1.78

21.76

1.7

1.6

8.68

7.11

ug/l

0.71

325

1188

Other arrhythmias

348

1469

1.77

21.42

1.7

1.5

11.47

7.53

ug/l

0.84

318

1355

Polyarthropathies

321

1127

1.83

21.38

1.7

1.6

12.19

8.07

ug/l

0.82

299

1026

Haemorrhage from respiratory passages

158

602

2.33

21.37

1.4

1.6

9.40

8.43

ug/l

0.24

140

549

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

258

1334

1.92

21.34

1.4

1.5

8.95

7.12

ug/l

0.50

238

1210

Generalized anxiety disorder

132

530

2.51

21.34

1.3

1.4

6.24

6.54

ug/l

0.13

121

474

Used for control exclusion in common control thyroid runs

543

1709

1.61

21.28

1.4

1.6

7.64

7.97

ug/l

0.12

489

1569

Spinal stenosis

206

719

2.12

21.27

1.6

15.51

9.11

ug/l

0.81

187

659

Sleep disorders

490

2088

1.62

21.26

1.4

1.6

6.56

8.71

ug/l

2.37

453

1908

Infections, IBD-co-morbidities

179

3.36

21.24

1.6

1.8

10.06

8.27

ug/l

0.30

164

Other diseases of lip and oral mucosa

237

1210

1.97

21.21

1.5

6.02

8.46

ug/l

3.28

210

1111

Other symptoms and signs involving the nervous and musculoskeletal systems

230

1165

1.98

21.04

1.5

8.08

8.28

ug/l

0.05

210

1057

Inflammatory diseases of female pelvic organs

391

1566

1.72

21.01

1.5

7.48

7.50

ug/l

0.01

352

1424

Voice disturbances

159

701

2.28

20.91

1.5

7.42

8.01

ug/l

0.19

144

636

Dentofacial anomalies [including malocclusion]

421

1983

1.67

20.86

1.4

1.6

6.22

7.82

ug/l

2.26

381

1810

Pain in thoracic spine

101

359

2.84

20.86

1.6

6.71

8.54

ug/l

0.84

319

Erysipelas

262

1191

1.90

20.72

1.5

1.6

14.29

8.16

ug/l

1.05

242

1095

Panic disorder

117

451

2.62

20.67

1.3

1.4

12.98

6.57

ug/l

0.45

106

405

Symptoms and signs involving speech and voice

183

864

2.13

20.32

1.5

9.67

9.09

ug/l

0.09

166

783

Transport accidents

227

954

1.99

20.26

1.4

1.5

12.76

8.01

ug/l

0.60

205

897

Provisional assignment of new diseases of uncertain etiology

287

1570

1.82

20.18

1.5

7.64

8.59

ug/l

0.37

260

1431

Haemorrhoids and perianal venous thrombosis

172

789

2.17

20.13

1.4

1.6

10.16

9.43

ug/l

0.10

158

728

Benzodiazepine use

521

2236

1.58

20.13

1.5

8.27

8.18

ug/l

0.03

478

2046

Symptoms and signs concerning food and fluid intake

190

3.55

20.11

1.8

1.5

9.09

7.71

ug/l

0.20

170

Dislocation, sprain and strain of joints and ligaments at neck level

120

475

2.55

20.10

1.2

1.5

6.70

7.08

ug/l

0.07

107

430

Codes for special purposes

287

1572

1.82

20.09

1.5

7.64

8.59

ug/l

0.37

260

1433

Diseases of the eye and adnexa

425

1271

1.68

19.85

1.4

1.6

6.42

7.85

ug/l

1.45

393

1142

Arthrosis

318

962

1.82

19.83

1.5

1.6

7.72

8.54

ug/l

0.35

289

874

Covid-19 confirmed case

193

939

2.06

19.71

1.5

1.6

8.60

9.22

ug/l

0.15

176

859

ILD medications: azathioprine

305

2.94

19.67

1.2

1.5

5.70

7.91

ug/l

1.89

275

Other symptoms and signs involving the digestive system and abdomen

360

2.77

19.61

1.5

1.6

6.90

8.28

ug/l

0.56

319

Any mental disorder

542

1729

1.57

19.56

1.5

1.6

8.87

8.32

ug/l

0.13

497

1575

Oxicams

110

223

2.81

19.34

1.3

1.6

6.86

12.17

ug/l

0.82

102

208

Other bacterial diseases

457

1887

1.61

19.14

1.6

1.5

11.92

7.72

ug/l

1.25

413

1738

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

463

1960

1.60

19.00

1.5

10.76

7.53

ug/l

0.92

425

1797

Polyarthrosis

104

351

2.68

18.98

1.7

1.6

8.72

8.90

ug/l

0.03

317

Abnormal findings on examination of blood, without diagnosis

216

1000

1.96

18.91

1.9

1.5

15.02

8.44

ug/l

0.99

204

912

Endocrine, nutritional and metabolic diseases

431

1322

1.65

18.89

1.4

1.5

7.07

7.26

ug/l

0.12

392

1206

Other disorders of bone

131

558

2.37

18.73

1.3

1.5

7.03

7.23

ug/l

0.05

117

506

Obesity

359

2031

1.67

18.55

1.4

1.5

6.73

8.42

ug/l

1.87

329

1850

Sequelae with surgical and medical care as external cause

115

464

2.50

18.52

1.6

1.5

8.24

8.62

ug/l

0.10

103

422

Obesity and other hyperalimentation

360

2036

1.67

18.51

1.4

1.5

6.73

8.43

ug/l

1.90

330

1855

Disorders of thyroid, IBD co-morbidities

219

2.92

18.50

1.7

11.54

7.61

ug/l

0.41

200

Condition for Implicit Sepsis (Organ dysfunction codes)

422

1807

1.62

18.49

1.5

9.10

8.22

ug/l

0.30

388

1654

Autoimmune diseases excluding thyroid diseases

529

1852

1.55

18.33

1.5

1.6

8.43

8.23

ug/l

0.06

486

1700

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

305

1526

1.74

18.28

1.6

10.75

8.82

ug/l

0.53

283

1400

Heartburn

233

3.16

18.28

1.5

6.09

8.69

ug/l

1.28

205

Insomnia

477

2123

1.57

18.14

1.4

1.6

6.62

8.64

ug/l

2.13

441

1941

Disorders of the thyroid gland

480

1994

1.56

17.93

1.5

8.53

8.21

ug/l

0.11

437

1827

Oxycodone

175

721

2.08

17.92

1.6

12.21

9.33

ug/l

0.47

162

663

Other inflammation of eyelid, including avohilmo

266

1492

1.79

17.84

1.5

7.33

7.34

ug/l

0.01

244

1362

Benign neoplasm: Colon

234

1180

1.87

17.82

1.6

10.29

9.38

ug/l

0.18

224

1081

L04AA Selective immunosuppressants

138

615

2.26

17.79

1.4

1.6

8.74

7.94

ug/l

0.25

131

559

Azathioprine

323

2.78

17.75

1.2

1.5

5.70

7.72

ug/l

1.80

290

Nonorganic sleeping disorders, excluding more controls

131

572

2.31

17.71

1.5

5.71

6.82

ug/l

1.03

124

520

Intracranial injury

304

1649

1.72

17.67

1.6

1.5

8.51

8.11

ug/l

0.12

278

1507

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

193

3.37

17.64

1.7

1.5

7.69

7.81

ug/l

0.02

169

Personality disorders, excluding more controls

157

738

2.13

17.60

1.4

1.5

7.48

6.80

ug/l

0.17

145

666

Hypertension, essential

391

1344

1.65

17.58

1.7

1.5

8.76

7.81

ug/l

0.51

358

1230

Autoimmune diseases excluding thyroid diseases, strict definition

509

1793

1.55

17.49

1.5

1.6

8.61

7.96

ug/l

0.24

466

1647

Internal derangement of knee

180

886

2.02

17.43

1.4

1.6

5.99

8.65

ug/l

3.36

171

807

Ovarian cyst

206

591

2.00

17.36

1.5

1.4

5.95

6.86

ug/l

0.84

192

528

Other disorders of patella

102

402

2.56

17.29

1.4

1.5

6.01

7.00

ug/l

0.71

361

Hypertensive diseases (excluding secondary)

290

952

1.78

17.19

1.4

1.5

6.82

7.49

ug/l

0.44

267

871

Viral warts, including avohilmo

144

665

2.18

17.03

1.9

1.5

9.58

7.02

ug/l

0.54

135

596

Injuries to the neck

148

691

2.16

17.03

1.2

1.5

6.61

7.19

ug/l

0.14

134

630

Other bacterial diseases, including avohilmo

500

2043

1.53

16.86

1.6

1.5

11.50

7.44

ug/l

1.33

449

1881

Implicit bacterial Sepsis, including avohilmo

199

855

1.94

16.75

1.5

1.6

11.20

9.62

ug/l

0.27

183

779

Injuries to the abdomen, lower back, lumbar spine and pelvis

205

1066

1.90

16.71

1.8

1.5

15.25

7.57

ug/l

1.14

191

975

Benign neoplasm of colon, rectum, anus and anal canal

272

1313

1.76

16.69

1.6

10.52

9.52

ug/l

0.22

259

1204

Leisure time condition

115

489

2.37

16.57

1.5

7.00

7.76

ug/l

0.35

106

432

Cystitis

428

1613

1.58

16.51

1.4

1.5

7.71

8.23

ug/l

0.18

393

1479

Erysipelas, including avohilmo

334

1490

1.66

16.51

1.4

1.5

12.93

8.25

ug/l

0.99

307

1371

Excessive, frequent and irregular menstruation

225

630

1.92

16.46

1.6

1.4

7.24

6.74

ug/l

0.12

204

566

Cervicocranial syndrome

233

3.03

16.37

1.5

1.7

7.17

9.22

ug/l

0.64

209

Candidiasis

384

2.55

16.34

1.5

7.30

8.01

ug/l

0.21

343

Gonarthrosis

262

821

1.81

16.34

1.4

1.6

7.14

9.02

ug/l

1.33

236

746

Endometriosis

193

564

2.00

16.28

1.5

1.4

6.72

6.95

ug/l

0.11

176

505

Autoimmune diseases

550

1863

1.50

16.26

1.4

1.6

7.82

8.22

ug/l

0.16

496

1709

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

346

2.61

15.91

1.9

1.6

9.24

7.41

ug/l

0.20

308

Non-selective monoamine reuptake inhibitors

173

841

1.98

15.85

1.6

1.7

7.49

10.22

ug/l

1.28

161

773

Influenza and pneumonia

545

2271

1.48

15.84

1.7

1.5

9.93

7.40

ug/l

1.27

494

2082

Primary_lymphoid and hematopoietic malignant neoplasms

114

493

2.33

15.81

3.1

1.5

16.78

10.72

ug/l

1.18

109

444

Childhood allergy (age < 16)

120

431

2.31

15.78

1.7

1.4

9.63

5.33

ug/l

0.67

110

383

Other and unspecified tonsillitis

193

839

1.92

15.72

1.5

6.41

7.18

ug/l

0.42

176

751

Implicit bacterial Sepsis

175

760

1.98

15.71

1.5

1.6

11.99

9.75

ug/l

0.36

162

692

Cholecystectomy

334

1742

1.63

15.68

1.5

10.33

8.37

ug/l

0.36

304

1594

Diseases of the digestive system

206

1104

1.86

15.67

1.7

1.5

13.26

8.66

ug/l

1.11

189

1007

Diseases of the ear and mastoid process

574

1953

1.48

15.59

1.5

7.58

8.36

ug/l

0.38

522

1784

Diseases of external ear

182

947

1.93

15.57

1.6

10.04

8.78

ug/l

0.17

168

865

Constipation

427

1870

1.55

15.54

1.4

1.6

7.54

8.63

ug/l

0.75

387

1720

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

175

904

1.95

15.32

1.6

1.5

6.89

7.35

ug/l

0.26

165

823

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

135

636

2.14

15.26

1.3

1.5

5.38

6.83

ug/l

1.85

124

572

Fall on same level

587

2151

1.46

15.19

1.4

1.5

9.52

7.64

ug/l

0.58

530

1974

Impingement syndrome of shoulder

110

477

2.32

15.18

1.3

1.8

7.81

9.72

ug/l

0.65

105

438

Diaphragmatic hernia

164

831

1.98

15.17

1.7

1.6

7.27

10.45

ug/l

1.73

157

757

Striking against or struck by other objects

192

1025

1.88

15.13

1.7

1.5

10.47

7.13

ug/l

0.77

178

933

Algoneurodystrophy

4.29

15.11

1.5

6.06

6.94

ug/l

0.23

Obesity, other/unspecified

203

1107

1.84

15.05

1.5

6.77

7.48

ug/l

0.48

185

1007

Psychiatric diseases

456

1491

1.54

14.95

1.5

1.6

9.39

8.41

ug/l

0.21

415

1366

Unspecified fall

254

1455

1.72

14.86

1.5

1.6

7.71

8.75

ug/l

0.30

233

1335

Conjunctivitis (acute, non atopic)

162

823

1.97

14.70

1.4

1.6

7.05

7.52

ug/l

0.12

155

743

Hypertension

389

1395

1.58

14.70

1.6

1.5

8.26

7.72

ug/l

0.26

355

1278

Disorders of vestibular function (Vertigo)

215

1169

1.80

14.68

1.4

1.6

6.79

9.45

ug/l

1.89

195

1073

Hypertensive diseases

389

1398

1.57

14.58

1.6

1.5

8.26

7.72

ug/l

0.26

355

1280

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

493

2101

1.49

14.55

1.5

10.67

7.56

ug/l

0.91

438

1933

Bacterial Sepsis

200

898

1.85

14.52

1.5

1.6

11.42

9.50

ug/l

0.35

183

817

Other specified/unspecified arthritis

128

603

2.13

14.46

1.8

1.6

11.73

8.77

ug/l

0.44

122

546

Symptoms and signs involving the urinary system

343

1625

1.60

14.45

1.5

9.65

8.50

ug/l

0.20

315

1491

In situ neoplasms

187

1007

1.86

14.44

1.6

1.5

13.31

7.79

ug/l

0.68

178

910

Obesity due to excess calories

270

1619

1.67

14.38

1.3

1.5

6.98

7.81

ug/l

0.74

247

1480

Bacterial infection, other or unspecified, including avohilmo

258

1241

1.71

14.36

1.4

1.5

12.11

7.75

ug/l

1.35

230

1149

Superficial injury of ankle and foot

367

2.47

14.31

1.3

1.5

7.75

7.13

ug/l

0.08

328

Melanocytic naevi of upper limb, including shoulder

5.04

14.12

2.0

1.4

14.30

6.75

ug/l

0.55

Exclusions for E4_PCOS_BROAD

110

494

2.24

14.01

1.8

1.5

9.65

7.58

ug/l

0.27

442

Oter anti-inflammatory and antirheumatic agents, non-steroids

176

2.70

14.00

1.4

1.7

7.76

13.93

ug/l

0.71

163

L04AX Other immunosuppressants

283

1729

1.64

13.97

1.5

1.6

7.31

8.88

ug/l

0.58

256

1589

Injuries to the knee and lower leg

587

2221

1.43

13.90

1.4

1.6

7.87

8.35

ug/l

0.25

530

2039

Endometriosis of pelvic peritoneum

102

402

2.32

13.89

1.4

5.72

6.72

ug/l

0.84

356

Carpal tunnel syndrome

287

1521

1.64

13.83

1.4

1.6

8.41

9.01

ug/l

0.17

266

1383

Other arthritis (FG)

150

766

1.97

13.63

1.7

1.6

11.03

8.60

ug/l

0.41

141

701

Other diseases of anus and rectum

137

675

2.03

13.61

1.6

10.83

10.00

ug/l

0.13

128

621

Falls/tendency to fall

529

1821

1.46

13.61

1.4

1.5

8.51

7.67

ug/l

0.22

481

1670

Hypothyroidism, strict autoimmune

354

1484

1.57

13.58

1.4

1.5

7.01

8.19

ug/l

0.84

319

1355

Other disorders of urethra and urinary system

343

1519

1.57

13.51

1.7

1.5

10.33

8.33

ug/l

0.54

313

1392

Second line medication for Crohn's disease

290

1799

1.62

13.46

1.5

1.6

7.76

8.72

ug/l

0.30

263

1654

Injuries to the wrist and hand

507

2321

1.45

13.45

1.5

7.30

8.42

ug/l

0.79

471

2117

Hernia of abdominal wall, postoperative

345

2.46

13.41

1.6

1.3

8.31

7.20

ug/l

0.28

313

Unspecified/other endometriosis

266

2.68

13.41

1.3

5.04

6.11

ug/l

1.04

233

KRA_PSY_EATING, excluding more controls

231

2.81

13.35

1.3

1.4

4.76

5.88

ug/l

1.13

205

Hyperkinetic disorders, excluding more controls

386

2.34

13.34

1.5

5.45

5.69

ug/l

0.18

343

Meniscus derangement

221

833

1.76

13.32

1.5

1.6

9.58

8.94

ug/l

0.12

207

760

Other heart diseases

253

973

1.70

13.18

2.0

1.5

10.66

7.43

ug/l

1.18

236

893

Lichen simplex chronicus and prurigo

3.98

13.16

1.3

1.8

10.98

11.64

ug/l

0.06

Cellulitis

120

574

2.10

13.09

1.5

9.92

7.66

ug/l

0.50

109

528

Diseases of inner ear

240

1368

1.68

13.03

1.4

1.6

6.70

9.55

ug/l

2.44

220

1257

Bacterial infection, other or unspecified

228

1124

1.72

13.03

1.4

1.5

12.10

7.96

ug/l

1.13

203

1036

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

237

870

1.72

12.99

1.6

1.5

7.76

7.53

ug/l

0.09

221

791

Other spirochaetal diseases, including avohilmo

173

942

1.84

12.97

1.5

6.05

8.16

ug/l

2.66

166

853

Lyme disease

170

923

1.85

12.87

1.5

6.09

8.15

ug/l

2.52

163

839

Lyme disease, including avohilmo

170

923

1.85

12.87

1.5

6.09

8.15

ug/l

2.52

163

839

Abnormal findings on diagnostic imaging of lung

191

1015

1.79

12.84

1.6

12.54

9.33

ug/l

0.59

177

930

Herpesviral [herpes simplex] infections, including avohilmo

154

814

1.90

12.69

1.4

1.5

7.34

7.16

ug/l

0.04

139

734

Other inflammation of eyelid

346

2.42

12.63

1.5

1.7

7.10

8.75

ug/l

0.68

313

Other spirochaetal diseases

170

933

1.83

12.45

1.5

6.09

8.12

ug/l

2.48

163

846

Gonarthrosis [arthrosis of knee](FG)

304

1096

1.60

12.38

1.4

1.7

7.57

9.20

ug/l

1.11

274

1007

Spirochaetal infections, other/unspecified, including avohilmo

170

935

1.83

12.37

1.5

6.09

8.17

ug/l

2.58

163

848

Congenital malformations and deformations of the musculoskeletal system

283

2.56

12.29

1.4

1.6

5.26

7.00

ug/l

1.10

253

Irregular menses

297

1412

1.59

12.24

1.6

1.5

7.98

7.24

ug/l

0.20

270

1269

Coxibs

119

289

2.17

12.18

1.6

6.74

11.70

ug/l

0.92

106

266

Nonalcoholic fatty liver disease

269

2.59

12.13

1.4

1.5

11.61

8.18

ug/l

0.27

239

Malignant neoplasm, including Hilmo

398

1554

1.49

12.03

2.2

1.4

10.35

6.97

ug/l

2.23

371

1399

Artrosis, including avohilmo

369

1330

1.52

12.00

1.4

1.5

6.82

8.70

ug/l

1.42

334

1222

Hypothyreosis and Thyroxine purchase for inclusion criteria

441

1987

1.46

11.98

1.5

8.75

8.16

ug/l

0.20

398

1822

Hypothyroidism, other/unspecified

420

1882

1.47

11.97

1.5

8.57

8.19

ug/l

0.12

380

1723

Other viral diseases, not elsewhere classified, including avohilmo

163

890

1.83

11.91

1.5

6.48

6.92

ug/l

0.31

150

812

Tonsillectomy and adenotomy

333

1511

1.54

11.89

1.4

1.5

5.54

7.30

ug/l

3.34

308

1368

Convulsions, not elsewhere classified

106

496

2.12

11.86

1.7

1.6

13.09

9.28

ug/l

0.38

457

Ethmoidectomy

326

2.41

11.84

1.4

1.6

9.18

7.83

ug/l

0.21

297

Diverticular disease of intestine

284

1107

1.60

11.82

1.5

1.6

7.55

9.55

ug/l

1.04

265

1024

Other neurological diseases

303

1508

1.56

11.82

1.4

1.5

12.70

8.41

ug/l

0.79

282

1381

Care involving use of rehabilitation procedures

293

1689

1.56

11.76

1.8

1.5

10.23

7.76

ug/l

0.85

271

1543

Pain associated with micturition

303

2.46

11.74

1.5

6.87

8.48

ug/l

0.69

266

Urinary track infection

340

1104

1.55

11.67

1.3

1.5

6.18

7.33

ug/l

1.07

308

1004

Malignant neoplasm, wide definition

396

1554

1.49

11.67

2.2

1.4

10.39

6.96

ug/l

2.26

369

1399

Other diseases of urinary system

461

1795

1.44

11.66

1.4

1.5

7.92

8.22

ug/l

0.11

418

1647

Other and unspecified iron deficiency

157

857

1.84

11.65

1.5

1.6

8.69

9.10

ug/l

0.09

149

778

Other diseases of liver

103

488

2.12

11.59

1.5

1.6

10.09

8.10

ug/l

0.23

442

Other and unspecified diseases of blood and blood-forming organs

4.90

11.47

2.8

1.3

11.14

6.60

ug/l

1.20

Disease of hard tissues of teeth, NOS

226

698

1.70

11.41

1.5

1.6

8.99

7.92

ug/l

0.30

209

649

Selective serotonin reuptake inhibitors

451

1627

1.44

11.23

1.4

1.6

8.18

8.90

ug/l

0.25

410

1492

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

149

801

1.84

11.22

1.3

1.5

8.15

6.86

ug/l

0.34

136

723

Genitourinary diseases

254

777

1.64

11.22

1.6

1.5

7.48

7.08

ug/l

0.21

229

712

Other viral diseases, including avohilmo

219

1319

1.65

11.16

1.4

1.5

7.58

7.14

ug/l

0.15

200

1204

Zoster [herpes zoster], including avohilmo

223

1319

1.64

10.97

1.7

1.5

7.99

9.47

ug/l

0.59

205

1205

Deforming dorsopathies

126

655

1.93

10.96

1.8

1.6

8.58

7.92

ug/l

0.16

116

597

Other and unspecified disorders of skin and subcutaneous tissue

127

3.26

10.95

1.5

1.7

6.30

8.28

ug/l

0.77

109

Other sleep disorders

236

2.60

10.92

1.3

1.4

6.05

8.31

ug/l

0.92

213

Other bacterial intestinal infections, including avohilmo

115

581

1.99

10.90

1.6

10.48

8.27

ug/l

0.41

103

526

FESS (DNB20)

314

2.37

10.90

1.4

1.6

9.23

7.93

ug/l

0.19

286

Other and unspecified nerve root and plexus disorders, also in other diseases

107

527

2.04

10.89

1.6

7.37

7.96

ug/l

0.20

479

Polyneuropathies and other disorders of the peripheral nervous system

448

2.13

10.84

1.3

1.5

13.92

10.41

ug/l

0.31

404

Nonorganic sleeping disorders

131

695

1.90

10.77

1.5

1.4

5.71

6.97

ug/l

1.17

124

624

Other enthesopathy of foot (+metatarsalgia)

232

2.61

10.76

1.3

1.8

5.44

8.53

ug/l

1.81

209

Cholelithiasis, broad definition with cholecystitis

386

1763

1.46

10.72

1.6

1.5

10.46

8.13

ug/l

0.51

352

1608

Other disorders of fluid, electrolyte and acid-base balance

131

653

1.90

10.71

1.2

1.6

9.99

9.49

ug/l

0.12

115

600

Malignant neoplasm

377

1507

1.47

10.53

2.2

1.4

10.54

7.01

ug/l

2.19

349

1356

Misadventures to patients during surgical and medical care

319

2.33

10.52

1.6

1.5

7.39

8.33

ug/l

0.29

284

Cholelithiasis

370

1730

1.46

10.43

1.6

1.5

10.05

8.17

ug/l

0.38

337

1577

Malignant neoplasm

376

1508

1.46

10.34

2.2

1.4

10.56

7.01

ug/l

2.20

348

1357

Otitis externa

123

650

1.90

10.25

1.8

1.5

9.04

7.89

ug/l

0.16

111

587

Brachial plexus disorders

250

2.50

10.23

1.2

1.5

8.62

7.01

ug/l

0.17

226

Chondropathies

420

2.13

10.19

1.3

1.5

5.34

7.53

ug/l

2.29

375

Nontoxic multinodular goitre

427

2.12

10.15

1.4

1.6

7.78

8.68

ug/l

0.30

379

Osteoporosis

108

501

1.99

10.13

3.0

1.5

16.65

9.78

ug/l

1.23

453

Metatarsalgia

216

2.61

10.12

1.3

1.8

5.46

8.55

ug/l

1.64

195

Menorrhagia

164

513

1.79

10.08

1.4

5.98

7.18

ug/l

1.09

152

459

Other diseases of hard tissues of teeth

223

703

1.65

10.07

1.4

1.6

7.38

7.89

ug/l

0.20

199

654

Other viral diseases

164

948

1.73

10.05

1.5

7.92

6.72

ug/l

0.37

154

862

Other diseases of the digestive system

124

662

1.88

10.01

1.8

1.6

16.43

10.16

ug/l

0.83

111

606

Disorders of adult personality and behaviour

167

977

1.72

9.95

1.4

1.5

7.95

6.68

ug/l

0.37

154

883

Other viral diseases, not elsewhere classified

107

544

1.97

9.91

1.4

1.5

6.16

7.34

ug/l

0.82

102

490

Caries of enamel

466

2200

1.39

9.81

1.4

1.6

6.13

8.29

ug/l

5.13

429

2007

Chronic gastritis

100

500

2.01

9.80

1.5

1.6

9.39

10.80

ug/l

0.22

450

Rheumatoid arthritis

125

593

1.87

9.78

1.5

1.6

8.33

9.20

ug/l

0.19

115

542

Otitis externa, unspecified

311

2.30

9.77

2.1

1.5

10.40

8.37

ug/l

0.17

276

Personality disorders

157

908

1.74

9.76

1.4

1.5

7.48

6.83

ug/l

0.17

145

823

Paroxysmal tachycardia

112

480

1.95

9.72

1.9

1.5

10.46

7.44

ug/l

0.57

103

445

Metabolic disorders

422

1795

1.41

9.70

1.5

1.6

10.15

8.17

ug/l

0.48

389

1646

All pneumoniae

485

2293

1.38

9.69

1.8

1.5

12.39

7.37

ug/l

1.65

440

2103

Disorders of gallbladder, biliary tract and pancreas

431

1914

1.40

9.61

1.6

1.5

10.67

8.02

ug/l

0.70

392

1749

Cutaneous abscess, furuncle and carbuncle

136

758

1.80

9.60

1.5

11.95

7.21

ug/l

0.73

117

701

Chronic apical periodontitis

524

2161

1.36

9.56

1.7

1.5

11.48

7.47

ug/l

1.37

478

1976

Polycystic ovarian syndrome, consortium definition

388

1560

1.43

9.47

1.5

7.74

7.32

ug/l

0.14

357

1410

Iron deficiency anaemia

184

1097

1.65

9.46

1.6

1.5

8.80

8.83

ug/l

0.01

174

997

380

2.14

9.44

1.3

1.5

5.36

7.13

ug/l

2.10

347

Other and unspecified polyneuropathies, also in other diseases

393

2.12

9.44

1.3

1.5

14.98

10.40

ug/l

0.37

351

Nonsuppurative otitis media, including avohilmo

184

964

1.66

9.41

1.6

1.5

7.68

7.11

ug/l

0.12

172

874

Melanoma in situ

3.62

9.40

2.3

1.5

14.48

9.03

ug/l

0.35

Major coronary heart disease event

334

1365

1.47

9.39

1.6

8.92

8.57

ug/l

0.14

306

1266

Vulvovaginal ulceration/inflammation in other diseases

213

2.56

9.38

2.3

1.5

12.48

7.28

ug/l

0.36

187

Percutaneous Coronary Intervention

319

1315

1.48

9.36

1.6

11.01

8.38

ug/l

0.50

291

1217

Dental pulpitis, including avohilmo

457

2123

1.38

9.33

1.5

9.33

7.70

ug/l

0.39

420

1935

Other hammer toe(s) (acquired)

275

2.29

9.31

2.0

1.6

10.41

9.31

ug/l

0.12

250

Amenorrhoea

185

2.67

9.28

2.2

1.3

16.85

5.75

ug/l

0.71

161

Venous thromboembolism

211

1283

1.59

9.27

1.5

1.6

7.18

9.58

ug/l

1.94

196

1180

Dislocation, sprain and strain of joints and ligaments of knee

309

1913

1.46

9.21

1.4

1.6

6.41

7.72

ug/l

1.53

281

1751

Lichen ruber planus, wide definition including periferal and oral lichen planus

105

548

1.93

9.14

1.5

1.6

6.31

8.44

ug/l

2.10

498

All kidney diseases

461

2254

1.37

9.14

1.6

1.5

11.45

7.64

ug/l

1.62

423

2061

Heart failure, not strict

288

1297

1.49

9.12

1.6

10.09

8.72

ug/l

0.42

265

1196

Other disorders starting during childhood or adolecense, excluding more controls

115

3.10

9.05

2.5

1.5

13.96

5.01

ug/l

0.54

105

Inflammatory disease of uterus

454

2.02

9.04

1.9

1.4

9.59

6.81

ug/l

0.31

406

Early onset COPD, excluding more controls

315

2.23

9.02

1.6

1.7

10.04

8.91

ug/l

0.19

298

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

143

825

1.74

9.00

1.5

6.46

7.51

ug/l

0.71

131

758

Coronary revascularization (ANGIO or CABG)

317

1315

1.47

8.98

1.5

1.6

10.84

8.38

ug/l

0.45

289

1217

Follicular cysts of skin and subcutaneous tissue

455

2.01

8.98

1.2

1.5

6.20

8.14

ug/l

1.67

410

Hard cardiovascular diseases

345

1414

1.44

8.97

1.5

1.6

8.06

8.45

ug/l

0.20

317

1314

Viral and other specified intestinal infections, including avohilmo

154

873

1.70

8.94

1.5

7.60

6.70

ug/l

0.27

146

785

Pneumonias (Asthma/COPD co-morbidities)

477

2294

1.36

8.91

1.8

1.5

12.44

7.37

ug/l

1.63

432

2104

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

148

750

1.73

8.89

1.8

1.5

7.67

6.00

ug/l

0.31

131

672

Pneumonia, organism unspecified

418

2070

1.39

8.89

1.7

1.5

12.17

7.59

ug/l

1.22

379

1904

Dermatophytosis, including avohilmo

300

2023

1.46

8.83

1.5

7.94

8.66

ug/l

0.23

275

1853

Emergency coronary revascularization (for ACS)

328

1366

1.45

8.82

1.6

10.93

8.77

ug/l

0.40

298

1267

Missing teeth due to accident, extraction or parodontitis

253

1500

1.51

8.81

1.4

1.6

10.03

9.38

ug/l

0.13

227

1383

Nutritional anaemias

204

1234

1.58

8.80

1.6

1.5

8.48

9.04

ug/l

0.17

194

1129

Other/unspecified enthesopathies of lower limb, excluding foot

162

2.74

8.76

1.4

1.7

11.41

9.23

ug/l

0.18

146

Benign paroxysmal vertigo

130

736

1.77

8.75

1.2

1.5

5.79

9.35

ug/l

2.28

120

664

Ischemic heart diseases

336

1389

1.44

8.71

1.5

1.6

8.27

ug/l

0.00

307

1287

Budesonide

315

2.20

8.64

2.0

1.6

8.67

8.18

ug/l

0.09

282

Other and unspecified disorders of vitreous body

174

1045

1.63

8.64

1.5

1.6

7.63

9.06

ug/l

0.58

163

961

Diseases of oral cavity, salivary glands and jaws

217

704

1.59

8.64

1.4

1.6

12.06

7.89

ug/l

0.52

188

655

Nonsuppurative otitis media

138

689

1.74

8.59

1.7

1.5

8.24

6.62

ug/l

0.29

128

618

Methotrexate

278

2.28

8.56

1.2

1.7

6.42

9.10

ug/l

1.37

249

Disorders of muscles

199

2.53

8.53

1.4

1.7

7.14

7.60

ug/l

0.11

179

Superficial injury of wrist and hand

117

648

1.81

8.50

1.6

7.34

7.20

ug/l

0.04

112

582

Polyuria

492

1.94

8.49

1.5

6.57

8.69

ug/l

1.13

448

Injuries to the head

517

2307

1.33

8.30

1.5

9.70

7.90

ug/l

0.51

470

2115

All influenza (not pneumonia)

361

2.09

8.24

1.2

1.6

17.46

8.28

ug/l

0.41

328

Paralytic ileus and intestinal obstruction

497

1.92

8.23

1.5

1.7

9.13

10.94

ug/l

0.33

462

Noninflammatory disorders of female genital tract

201

631

1.60

8.21

1.5

1.4

6.49

6.74

ug/l

0.11

180

566

Hypothyroidism, strict autoimmune, 3 medication purchases required

385

1871

1.38

8.15

1.3

1.5

6.88

8.24

ug/l

1.22

345

1719

Disturbance of activity and attention

501

1.90

8.14

1.5

5.17

5.85

ug/l

0.65

444

Specific personality disorders

132

768

1.73

8.13

1.4

1.5

8.61

6.77

ug/l

0.45

123

694

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

410

1891

1.37

8.12

1.5

8.34

8.51

ug/l

0.06

381

1729

Postmenopausal atrophic vaginitis

109

314

1.90

8.12

1.7

1.5

8.82

8.29

ug/l

0.10

100

282

Acute suppurative otitis media

156

883

1.65

8.09

1.7

1.5

8.55

6.28

ug/l

0.51

143

802

Biological medication for rheuma

102

553

1.85

7.98

1.4

1.5

6.11

7.19

ug/l

0.83

500

Conduction disorders

110

483

1.83

7.97

1.5

1.4

7.26

8.00

ug/l

0.29

101

444

Papulosquamous disorders

174

1093

1.60

7.96

1.4

1.5

6.90

8.66

ug/l

0.99

157

1004

Fall on same level involving ice and snow

262

1796

1.46

7.94

1.5

1.6

9.83

8.30

ug/l

0.21

245

1645

Superficial injury of lower leg

132

773

1.71

7.94

1.6

9.49

7.63

ug/l

0.42

118

704

Disorders of vitreous body

202

1249

1.54

7.89

1.5

1.6

9.43

9.89

ug/l

0.08

188

1145

Benign thyroid growths and nodules

138

760

1.69

7.85

1.8

1.6

12.02

8.37

ug/l

0.71

129

693

Diseases of middle ear and mastoid

289

1644

1.44

7.85

1.4

1.5

6.20

7.49

ug/l

1.23

264

1506

Disorders of vitreous body and globe

205

1266

1.53

7.83

1.5

1.6

9.37

9.84

ug/l

0.08

191

1159

GI-bleeding

116

659

1.76

7.76

1.8

1.6

17.36

10.17

ug/l

0.95

105

604

Benign neoplasm of other and ill-defined parts of digestive system

397

2.00

7.75

1.4

1.6

7.18

8.85

ug/l

0.98

357

Hyperkinetic disorders

100

530

1.85

7.74

1.6

1.5

5.45

5.77

ug/l

0.24

473

Hernia

401

1957

1.36

7.73

1.6

1.5

7.10

8.69

ug/l

1.42

372

1794

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

457

2282

1.33

7.68

1.8

1.5

12.69

7.42

ug/l

1.61

413

2094

Endometriosis ASRM stages 1,2

106

589

1.81

7.68

1.4

1.5

5.76

6.94

ug/l

1.01

531

Other diseases of pleura

153

812

1.64

7.68

1.7

1.6

13.63

10.13

ug/l

0.52

142

743

Any death

1208

0.55

7.66

1.5

1.6

9.58

9.02

ug/l

0.18

1108

Any event in cancer register

409

1757

1.36

7.64

2.2

1.4

10.17

7.31

ug/l

1.72

379

1591

Hernia of abdominal wall

184

1183

1.56

7.64

1.5

1.6

7.37

9.22

ug/l

0.92

166

1087

Coxarthrosis

167

665

1.62

7.63

1.3

1.7

7.57

9.52

ug/l

1.25

150

608

Other disorders of breast

414

1.97

7.59

1.9

1.5

9.62

7.55

ug/l

0.21

375

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

158

983

1.61

7.55

1.8

1.5

11.28

7.62

ug/l

0.73

144

896

Other abnormal uterine and vaginal bleeding

101

392

1.86

7.54

1.6

1.4

7.12

7.54

ug/l

0.16

348

Diseases of liver

146

892

1.64

7.51

1.5

1.6

11.01

9.11

ug/l

0.28

139

812

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

161

996

1.60

7.50

1.7

1.4

9.58

6.68

ug/l

0.61

153

891

Acne

380

2.00

7.47

1.3

1.4

5.68

5.98

ug/l

0.15

342

Disorders of breast

249

1504

1.46

7.43

1.7

1.5

7.94

7.51

ug/l

0.11

224

1372

Disorders of sclera, cornea, iris and ciliary body

241

1652

1.46

7.38

1.5

8.49

8.77

ug/l

0.07

221

1509

Other bacterial intestinal infections

392

1.97

7.30

1.7

1.6

12.91

8.53

ug/l

0.61

354

Procreative management

178

941

1.56

7.25

2.1

1.4

9.87

6.80

ug/l

0.73

165

867

Nontoxic goitre/thyroid nodule

124

734

1.70

7.22

1.9

1.5

11.97

8.08

ug/l

0.70

115

662

Gonarthrosis,primary

335

1454

1.39

7.22

1.3

1.7

7.56

9.81

ug/l

1.62

302

1345

Erythema intertrigo

4.53

7.19

1.1

1.4

5.11

6.48

ug/l

0.93

Reimbursement for rheumatic diseases

248

1708

1.45

7.17

1.7

1.5

9.17

8.70

ug/l

0.10

224

1565

Superficial injury of abdomen, lower back and pelvis

445

1.90

7.11

1.3

1.4

5.08

7.24

ug/l

2.62

400

Viral and other specified intestinal infections

112

633

1.73

7.04

1.6

1.5

8.44

6.93

ug/l

0.35

105

563

Panniculitis affecting regions of neck and back

3.52

7.00

2.0

1.9

6.53

8.77

ug/l

0.49

Unknown and unspecified causes of morbidity

124

2.76

6.95

1.3

1.7

6.78

7.80

ug/l

0.32

113

Acne vulgaris

284

2.12

6.94

1.3

1.4

5.67

6.00

ug/l

0.14

259

Use of hypnotics and sedatives

459

1993

1.32

6.93

1.5

9.10

8.25

ug/l

0.30

424

1826

5-aminosalicylic acid

464

1.86

6.88

1.3

1.6

6.76

8.07

ug/l

0.73

420

Bacterial intestinal infections, IBD co-morbidities

408

1.92

6.86

1.7

1.5

12.80

10.15

ug/l

0.28

365

Acetic acid derivatives and related substances

273

1.86

6.86

1.4

1.6

5.54

12.07

ug/l

1.32

252

Lichen planus, including avohilmo

465

1.86

6.85

1.6

6.43

8.79

ug/l

1.95

419

Bleeding

322

1638

1.38

6.83

1.7

1.5

11.67

8.46

ug/l

1.08

293

1510

Gastroduodenal ulcer

443

1.87

6.80

1.9

1.6

13.42

11.92

ug/l

0.17

404

Persons encountering health services for specific procedures, not carried out

229

2.24

6.75

1.5

11.73

8.07

ug/l

0.32

196

Persistent mood disorders

489

1.83

6.74

1.3

1.5

6.43

7.33

ug/l

0.64

436

Superficial injury of hip and thigh

335

2.01

6.71

2.0

1.5

13.98

8.29

ug/l

0.65

297

Dental operations

227

789

1.48

6.70

1.5

1.6

8.95

8.83

ug/l

0.03

201

738

Abnormal findings on diagnostic imaging of other body structures

344

1.99

6.62

1.9

1.5

16.15

8.27

ug/l

0.68

305

Other peripheral vertigo

200

2.32

6.57

1.2

1.6

6.44

8.52

ug/l

1.13

173

Unstable angina pectoris

113

524

1.70

6.43

1.6

9.84

9.12

ug/l

0.14

103

487

Infections with a predominantly sexual mode of transmission

166

1086

1.53

6.40

1.7

1.5

9.27

6.83

ug/l

0.49

155

986

Chronic kidney disease

100

556

1.73

6.36

1.5

1.6

14.83

10.92

ug/l

0.45

509

Hypothyroidism, drug reimbursement

210

2.07

6.31

1.3

1.4

9.81

7.84

ug/l

0.18

189

Artificial joint operation, meniscal resection

346

1643

1.35

6.29

1.4

1.6

8.57

9.17

ug/l

0.18

316

1519

Lesion of ulnar nerve

323

1.99

6.29

1.3

1.7

6.87

8.95

ug/l

1.01

292

Other symptoms and signs involving cognitive functions and awareness

168

979

1.52

6.28

1.6

9.72

9.64

ug/l

0.01

160

899

Myeloid leukaemia

3.88

6.28

3.8

1.2

28.22

6.51

ug/l

1.16

Infections with a predominantly sexual mode of transmission, including avohilmo

222

1416

1.44

6.22

1.7

1.5

8.85

6.59

ug/l

0.60

202

1286

Injuries to the shoulder and upper arm

360

2089

1.33

6.19

1.6

1.5

8.43

8.51

ug/l

0.02

328

1914

Hypo-osmolality and hyponatraemia

350

1.93

6.17

1.1

1.6

8.43

9.33

ug/l

0.19

319

Excessive attrition of teeth

292

2119

1.37

6.16

1.4

1.5

6.82

7.70

ug/l

0.77

268

1933

Fracture of lumbar spine and pelvis

466

1.80

6.14

2.2

1.4

26.57

8.31

ug/l

1.17

419

Other and unspecified anaemias

145

873

1.56

6.12

1.6

1.5

10.45

9.53

ug/l

0.20

124

807

Sequelae of injuries, of poisoning and of other consequences of external causes

109

654

1.67

6.11

1.6

1.5

8.53

7.58

ug/l

0.18

592

Other disorders of veins

172

1130

1.50

6.09

1.4

1.6

7.70

9.23

ug/l

0.70

157

1033

Other specified/unspecified soft tissue disorders

3.04

6.08

1.3

1.6

4.64

8.16

ug/l

1.53

Other anaemias

146

881

1.55

6.03

1.6

1.5

10.40

9.49

ug/l

0.20

125

814

Eating disorder

342

1.94

6.01

1.3

1.5

4.75

5.60

ug/l

1.02

303

Other/unspecified synovitis and tenosynovitis

235

2.14

5.96

1.2

1.8

6.31

8.78

ug/l

1.14

214

Recurrent aphthous stomatitis , including avohilmo

394

1.86

5.91

1.3

1.5

7.15

7.88

ug/l

0.25

346

Bruxism

3.46

5.90

1.5

4.74

6.74

ug/l

1.69

Renal failure

153

851

1.53

5.89

1.4

1.6

12.40

10.08

ug/l

0.39

142

778

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

232

2.13

5.89

1.7

1.4

4.61

6.33

ug/l

1.17

207

Other or unspecified immunodeficiency

11.82

5.89

1.3

7.49

ug/l

—

DVT of lower extremities and pulmonary embolism

146

945

1.54

5.88

1.4

1.6

7.21

10.00

ug/l

1.71

135

863

Umbilical hernia

111

677

1.64

5.86

1.5

1.6

6.61

8.95

ug/l

1.80

618

Thyroiditis, ILD-related definition

318

1.96

5.85

1.3

1.4

5.86

6.73

ug/l

0.62

287

Mixed and other personality disorders

237

2.13

5.85

1.5

5.25

8.10

ug/l

1.81

211

Exclusions for E4_PCOS_CONSORTIUM

353

1660

1.33

5.84

1.6

1.5

8.65

7.41

ug/l

0.43

319

1509

Disorders of ocular muscles, binocular movement, accommodation and refraction

232

1642

1.40

5.79

1.8

1.5

8.19

7.15

ug/l

0.29

213

1492

Explicit Sepsis, including avohilmo

164

992

1.50

5.77

1.9

1.5

13.45

8.49

ug/l

1.34

155

902

Secondary hypertension

135

2.49

5.74

1.2

1.6

10.86

8.65

ug/l

0.28

124

Carcinoma in situ of skin of upper limb, including shoulder

3.95

5.73

1.4

1.3

8.00

8.52

ug/l

0.07

Disorders of refraction and accommodation

146

953

1.53

5.70

1.8

1.5

8.93

6.95

ug/l

0.38

134

868

Injuries to the thorax

176

1200

1.47

5.64

1.6

1.5

11.76

8.80

ug/l

0.58

169

1097

Restless leg syndrome

372

1.86

5.63

1.1

1.5

5.26

8.26

ug/l

2.95

332

Appendectomy

296

2100

1.34

5.63

1.8

1.5

9.47

8.04

ug/l

0.32

269

1916

Diseases of arteries, arterioles and capillaries (FINNGEN)

366

1.74

5.62

1.4

1.7

11.59

8.34

ug/l

0.35

339

Eating disorders

379

1.86

5.61

1.3

1.5

4.55

5.61

ug/l

1.54

337

Aplastic and other anaemias

159

972

1.50

5.59

1.7

1.5

11.73

9.24

ug/l

0.56

138

898

Coxarthrosis [arthrosis of hip](FG)

182

853

1.47

5.56

1.4

1.7

7.98

9.62

ug/l

1.01

165

786

Phlebitis and thrombophlebitis (not including DVT)

566

1.68

5.52

1.6

1.5

6.71

9.56

ug/l

1.03

514

Endometriosis of ovary

406

1.79

5.51

1.5

1.4

7.27

7.49

ug/l

0.06

362

Seropositive rheumatoid arthritis

541

1.70

5.49

1.5

8.40

8.55

ug/l

0.03

497

Fibroblastic disorders

428

1.78

5.39

1.6

1.7

12.01

8.66

ug/l

0.40

394

Dental caries, including avohilmo

282

1060

1.36

5.37

1.5

11.24

7.70

ug/l

0.60

250

977

Other extrapyramidal and movement disorders in other diseases

601

1.65

5.37

1.1

1.6

5.40

8.59

ug/l

4.10

543

Other disorders starting during childhood or adolescence

159

2.32

5.36

2.5

1.5

13.96

5.25

ug/l

0.52

145

Suppurative and unspecified otitis media

186

1145

1.44

5.35

1.6

1.5

7.98

6.77

ug/l

0.28

169

1043

Tumor necrosis factor alpha inhibitors

511

1.71

5.35

1.4

1.5

5.93

7.28

ug/l

1.10

458

Diagnoses used for exclusion with ILD

556

1.68

5.34

1.3

1.6

11.38

9.92

ug/l

0.18

504

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

134

876

1.53

5.32

1.2

1.6

7.35

8.88

ug/l

1.03

122

806

Glucagon-like peptide-1 (GLP-1) analogues

134

876

1.53

5.32

1.2

1.6

7.35

8.88

ug/l

1.03

122

806

Solid cancers, including Hilmo

343

1519

1.32

5.32

1.6

1.4

8.41

6.97

ug/l

0.69

318

1367

Gonarthrosis, primary, with knee surgery

193

1049

1.43

5.31

1.4

1.7

7.80

10.70

ug/l

1.55

176

971

Open wound of lower leg

387

1.82

5.29

1.7

1.6

7.66

8.42

ug/l

0.25

340

Caries of dentine, including avohilmo

308

1175

1.34

5.29

1.5

10.73

7.48

ug/l

0.61

274

1080

Diseases of pulp and periapical tissues, including avohilmo

445

1809

1.27

5.24

1.5

8.78

7.61

ug/l

0.27

414

1651

Other acute skin changes due to ultraviolet radiation

3.16

5.20

1.2

1.6

7.52

7.18

ug/l

0.09

Adenomyosis (Endometriosis of uterus)

291

1.93

5.11

1.8

1.4

8.38

7.87

ug/l

0.12

258

Paracetamol or NSAID medication

150

1.99

5.09

1.4

1.3

6.37

5.73

ug/l

0.43

138

Zoster [herpes zoster]

414

1.77

5.09

2.3

1.5

11.19

7.79

ug/l

0.63

371

Tinnitus

572

1.65

5.07

1.4

1.6

7.84

8.08

ug/l

0.08

519

Other facial nerve disorders

3.20

5.05

1.1

1.7

5.71

7.99

ug/l

0.51

Exposure to other and unspecified man-made environmental factors

3.45

5.05

1.4

1.7

8.14

10.81

ug/l

0.28

Complications of internal orthopaedic prosthetic devices, implants and grafts

430

1.75

5.04

1.6

1.5

9.68

8.88

ug/l

0.09

390

Excessive vomiting in pregnancy

280

1.94

5.01

1.2

1.4

6.03

6.00

ug/l

0.01

249

Atrophic disorders of skin

387

1.79

5.00

1.6

6.72

7.80

ug/l

0.31

342

Acute appendicitis, no complications

250

1844

1.35

4.99

1.8

1.5

10.06

7.83

ug/l

0.46

226

1689

Diseases of arteries, arterioles and capillaries

221

1171

1.39

4.99

1.5

1.6

14.36

8.63

ug/l

0.82

211

1066

Other septicaemia

127

784

1.53

4.99

2.1

1.5

13.91

8.02

ug/l

1.56

120

721

Phobic anxiety disorders

409

1.76

4.96

1.7

1.5

7.83

6.53

ug/l

0.39

369

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

149

1013

1.48

4.94

1.3

1.5

8.15

6.76

ug/l

0.37

136

920

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

180

2.18

4.93

1.5

6.30

9.29

ug/l

1.28

160

Glaucoma suspect

128

844

1.52

4.91

1.2

1.6

6.45

9.82

ug/l

2.00

115

775

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

164

2.23

4.90

2.5

1.5

13.96

5.42

ug/l

0.51

147

Fall on and from stairs and steps

111

711

1.57

4.87

1.2

1.6

6.16

8.13

ug/l

1.56

100

641

Inflammatory bowel disease

140

944

1.49

4.85

1.7

1.5

8.56

7.38

ug/l

0.29

128

863

Ulcer of vagina/vulva

3.02

4.84

1.5

1.6

7.95

7.61

ug/l

0.03

Extrapyramidal and movement disorders

139

936

1.49

4.84

1.2

1.6

5.69

9.80

ug/l

3.53

127

860

Injuries to the hip and thigh

176

1109

1.42

4.82

1.7

1.5

15.94

8.12

ug/l

0.85

161

1011

Adalimumab

298

1.89

4.82

1.2

1.5

5.66

7.58

ug/l

1.10

267

Heart failure and antihypertensive medication

311

1.72

4.80

1.7

7.71

8.92

ug/l

0.49

290

Other septicaemia, including avohilmo

131

819

1.50

4.76

2.1

1.5

13.73

7.97

ug/l

1.59

124

753

Other female pelvic inflammatory diseases

423

1.73

4.76

1.1

1.6

5.34

7.76

ug/l

2.39

380

Explicit Sepsis

155

973

1.45

4.73

1.9

1.5

12.78

8.73

ug/l

1.06

146

886

Stomatitis and related lesions

599

1.61

4.72

1.6

1.5

7.15

7.41

ug/l

0.10

539

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

102

2.57

4.72

1.1

1.6

5.32

7.37

ug/l

0.80

Emotionally unstable personality disorder

417

1.74

4.71

1.2

1.5

8.03

6.79

ug/l

0.15

375

Fissure and fistula of anal and rectal regions

570

1.62

4.66

1.4

1.6

8.98

10.04

ug/l

0.15

522

Enterocolitis due to Clostridium difficile

198

2.08

4.64

1.4

1.5

9.18

8.34

ug/l

0.18

173

Other disorders of eyelid

146

944

1.46

4.63

1.6

14.85

9.13

ug/l

0.49

131

876

Other and unspecified mood [affective] disorders

206

2.05

4.57

1.3

1.6

4.82

6.73

ug/l

1.48

180

Intestinal stricture

105

675

1.56

4.56

1.5

1.7

8.91

10.10

ug/l

0.25

618

Propionic acid derivatives

100

310

1.63

4.56

1.4

1.6

8.07

11.27

ug/l

0.51

286

Other menopausal disorders

109

385

1.58

4.55

1.3

1.4

5.97

7.67

ug/l

1.39

100

346

Appendicitis, broad definition

317

2209

1.29

4.55

1.8

1.5

10.20

7.96

ug/l

0.56

284

2022

Septicaemia

142

885

1.46

4.54

2.0

1.5

13.53

8.00

ug/l

1.66

134

810

Spondyloarthritis

445

1.69

4.50

1.4

1.5

5.77

7.91

ug/l

2.27

403

Scar conditions and fibrosis of skin

111

2.45

4.47

2.0

1.5

10.29

7.17

ug/l

0.39

Idiopathic gout

142

2.26

4.47

1.6

1.7

10.07

9.43

ug/l

0.13

129

Transient ischemic attack

168

944

1.42

4.46

1.3

1.6

16.05

9.28

ug/l

0.69

157

861

Iridocyclitis

585

1.59

4.45

1.4

1.5

7.34

8.25

ug/l

0.43

531

Hallux valgus (acquired)

114

531

1.54

4.44

1.9

1.6

10.02

8.97

ug/l

0.18

106

482

Disorders of lipoprotein metabolism and other lipidaemias

307

1438

1.30

4.43

1.5

1.6

10.58

8.85

ug/l

0.28

285

1325

Diseases of appendix

318

2218

1.28

4.42

1.8

1.5

10.18

7.95

ug/l

0.56

285

2030

Type1 diabetes, definitions combined, early onset

221

0.22

4.40

1.0

1.5

48.16

6.58

ug/l

—

198

Autonomic disorders

3.13

4.37

1.6

1.5

5.97

6.79

ug/l

0.22

Benign neoplasm: Skin of upper limb, including shoulder

3.38

4.34

1.0

1.4

6.81

6.92

ug/l

0.03

Female infertility, cervical, vaginal, other or unspecified origin

126

538

1.50

4.31

1.3

1.4

5.42

6.48

ug/l

1.26

110

482

Other specified/unspecified systemic involvement of connective tissue

132

2.29

4.29

1.2

1.6

8.54

7.96

ug/l

0.07

116

Hypokalaemia

268

1.87

4.25

1.4

1.5

9.49

7.65

ug/l

0.47

240

Fracture of rib(s), sternum and thoracic spine

105

687

1.53

4.25

1.7

1.6

13.29

9.95

ug/l

0.40

100

628

Bitten or struck by other mammals

356

1.75

4.22

1.6

1.5

5.65

7.41

ug/l

1.02

319

Acute lymphadenitis

146

2.21

4.21

1.8

1.6

6.16

7.52

ug/l

0.31

131

Acute pancreatitis

424

1.68

4.19

1.4

1.5

7.58

7.84

ug/l

0.08

381

Fracture of foot, except ankle

111

738

1.51

4.18

1.4

1.6

9.02

7.40

ug/l

0.34

102

676

Inflammatory disorders of breast

207

1.99

4.16

1.8

1.5

6.78

7.03

ug/l

0.07

182

Other and unspecified abdominal hernia

2.68

4.16

1.6

1.4

7.17

8.43

ug/l

0.31

Varicella [chickenpox]

2.55

4.13

3.2

1.5

18.55

8.29

ug/l

0.34

Rheumatoid arthritis, including avohilmo

141

986

1.43

4.11

1.5

7.91

8.76

ug/l

0.20

131

898

Presence of other functional implants

192

962

1.37

4.06

1.5

1.6

10.89

8.81

ug/l

0.44

168

882

Ventral hernia

560

1.58

4.05

1.6

7.71

10.51

ug/l

0.67

511

Acute appendicitis

296

2155

1.28

4.00

1.9

1.5

10.39

7.92

ug/l

0.59

265

1971

Other symptoms and signs involving the urinary system

217

1.94

4.00

1.1

1.6

7.48

9.41

ug/l

0.39

195

Female infertility

134

551

1.46

4.00

1.2

1.4

5.38

6.52

ug/l

1.48

121

493

Solid cancers

319

1470

1.27

3.97

1.5

1.4

7.34

7.04

ug/l

0.19

294

1320

Osteonecrosis

124

2.27

3.96

2.4

1.5

16.46

7.83

ug/l

0.94

107

Superficial injury of shoulder and upper arm

326

1.76

3.95

1.4

11.53

8.01

ug/l

0.37

290

Spondylolisthesis/Spondylolysis

386

1.69

3.94

1.7

1.6

9.31

8.95

ug/l

0.05

348

Renal tubulo-interstitial diseases

358

2101

1.25

3.94

1.6

12.29

7.98

ug/l

1.40

320

1927

Anogenital herpesviral [herpes simplex] infection, including avohilmo

379

1.70

3.93

1.8

1.4

13.88

6.57

ug/l

0.60

335

Mouth breathing

153

1095

1.40

3.90

1.4

1.6

7.30

8.40

ug/l

0.82

136

1009

Residual foreign body in soft tissue

100

2.41

3.89

2.3

1.6

29.51

7.41

ug/l

0.88

Other disorders of conjunctiva

284

1.80

3.87

1.2

1.6

7.46

8.49

ug/l

0.26

250

Major coronary heart disease event excluding revascularizations

183

884

1.37

3.86

1.6

1.7

11.94

8.94

ug/l

0.61

164

817

Psoriatic arthropathies

213

1.93

3.86

1.4

1.5

7.90

8.01

ug/l

0.03

191

Other CVD

351

1.71

3.85

1.4

1.5

16.13

11.17

ug/l

0.30

315

Primary gonarthrosis, bilateral

168

1023

1.38

3.83

1.4

1.7

8.20

10.69

ug/l

1.03

155

946

Gingivitis and periodontal diseases

394

1643

1.24

3.82

1.5

7.83

8.02

ug/l

0.07

356

1514

Female genital prolapse

105

384

1.52

3.80

1.6

1.4

8.43

7.67

ug/l

0.13

345

All chronic kidney diseases

191

1131

1.35

3.79

1.4

1.6

10.90

8.83

ug/l

0.45

179

1031

Other disorders of ear

360

1870

1.24

3.78

1.5

1.6

8.59

8.76

ug/l

0.05

337

1709

Polycythaemia vera

3.02

3.69

1.9

1.4

10.91

9.10

ug/l

0.16

Haemorrhage, not elsewhere classified

3.02

3.69

1.1

1.7

5.27

9.93

ug/l

1.05

Acne, including avohilmo

128

724

1.43

3.68

1.4

6.51

6.27

ug/l

0.08

115

649

Type 1 diabetes, strict definition

267

0.33

3.68

1.0

1.5

32.54

6.67

ug/l

—

241

Other CVD (FINNGEN)

147

1.98

3.65

1.3

1.7

19.16

8.84

ug/l

0.46

140

Haemorrhage in early pregnancy

143

999

1.39

3.60

1.2

1.4

5.44

6.85

ug/l

1.69

121

901

Superficial injury of thorax

374

1.66

3.58

1.4

1.5

10.88

8.21

ug/l

0.33

334

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.67

3.57

1.4

6.42

7.52

ug/l

0.23

Type 1 diabetes, strict definition, subgroup 1

250

0.32

3.54

1.0

1.6

35.81

6.70

ug/l

—

227

Acute and subacute iridocyclitis

476

1.58

3.54

1.5

7.71

8.08

ug/l

0.13

432

Ischaemic heart disease, wide definition

258

1238

1.28

3.51

1.6

8.64

8.76

ug/l

0.04

232

1146

Cerebrovascular diseases (FINNGEN)

115

555

1.45

3.51

1.4

1.6

10.00

8.83

ug/l

0.13

109

510

Unspecified kidney failure

158

2.03

3.49

1.4

1.6

12.01

14.98

ug/l

0.21

140

Acute pancreatitis (for exclusion)

447

1.59

3.47

1.4

1.5

7.58

10.16

ug/l

0.64

399

Diseases of male genital organs

156

567

1.39

3.46

1.6

12.91

8.23

ug/l

0.45

146

525

Benign neoplasm: Skin of scalp and neck

2.79

3.43

1.2

1.4

5.24

6.31

ug/l

0.57

Covid-19 suspected case

100

682

1.47

3.41

1.5

5.78

7.17

ug/l

1.31

613

Other and unspecified disorders of autonomic nervous system

7.25

3.40

1.3

4.74

9.13

ug/l

—

Glaucoma

179

1143

1.33

3.36

1.4

1.6

8.39

9.76

ug/l

0.44

164

1055

Hyperlipidaemia, other/unspecified

122

776

1.41

3.36

1.5

1.7

7.51

9.76

ug/l

1.35

115

712

Fracture of lower leg, including ankle

212

1608

1.30

3.34

1.2

1.6

8.74

8.86

ug/l

0.03

191

1485

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

219

1471

1.29

3.33

1.5

7.67

7.13

ug/l

0.18

198

1337

Other noninflammatory disorders of uterus, except cervix

302

1.59

3.33

1.8

1.5

8.73

8.29

ug/l

0.08

273

Diseases of pulp and periapical tissues and dental caries

237

941

1.29

3.32

1.6

1.5

12.29

7.52

ug/l

0.72

210

869

Open wound of wrist and hand

182

1335

1.32

3.26

1.7

1.5

7.98

8.11

ug/l

0.03

168

1216

Psoriatic and enteropathic arthropathies

263

1.76

3.26

1.3

1.8

7.55

9.87

ug/l

0.77

240

Psoriasis vulgaris

463

1.56

3.25

1.5

7.73

7.87

ug/l

0.03

422

Pacemaker

616

1.47

3.25

1.6

19.41

10.52

ug/l

0.50

570

Lactose intolerance

2.40

3.23

1.5

6.46

5.60

ug/l

0.34

Sulfasalazine

617

1.48

3.21

1.6

9.15

9.14

ug/l

0.00

559

Pure hypercholesterolaemia

259

1303

1.26

3.16

1.5

1.6

11.50

9.14

ug/l

0.34

241

1199

Other cataract

145

791

1.36

3.15

1.7

1.6

16.30

8.57

ug/l

0.69

134

727

Benign neoplasm of mouth and pharynx

244

1.77

3.14

1.3

1.5

6.66

8.98

ug/l

1.10

216

Foreign body in respiratory tract

125

2.09

3.08

1.7

1.6

5.28

7.21

ug/l

0.96

110

Benign lipomatous neoplasm

106

747

1.42

3.07

1.6

9.13

9.23

ug/l

0.02

677

Bacterial pneumonia (organism specified)

143

957

1.35

3.07

2.1

1.5

15.71

8.82

ug/l

1.14

132

882

Anti-inflammatory and antirheumatic products, non-steroids

310

1.49

3.07

1.2

1.6

6.94

11.27

ug/l

0.80

286

Ulcerative colitis, NAS

383

1.60

3.07

1.6

1.4

6.31

8.11

ug/l

1.08

340

Seropositive rheumatoid arthritis, wide

632

1.46

3.06

1.5

8.40

9.41

ug/l

0.16

570

Varicella [chickenpox], including avohilmo

112

2.15

3.06

3.1

1.5

17.96

7.67

ug/l

0.36

103

Use of donepezil

287

0.36

3.05

1.5

6.65

12.83

ug/l

1.31

258

Ulcerative proctitis

160

1.95

3.04

1.1

1.5

4.60

8.72

ug/l

1.93

139

Coeliac disease

316

1.65

2.99

1.6

1.5

9.15

7.80

ug/l

0.28

281

Poisoning by medicine

694

1.43

2.97

1.3

1.5

9.80

6.81

ug/l

0.61

622

Postprocedural disorders of digestive system, not elsewhere classified

2.42

2.97

1.3

1.5

5.33

6.42

ug/l

0.43

Scabies, including avohilmo

490

1.51

2.96

1.4

1.5

6.24

6.91

ug/l

0.36

438

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

105

745

1.41

2.95

2.1

1.4

12.18

6.46

ug/l

0.84

100

674

Ascites

114

2.11

2.94

1.3

1.4

13.65

8.58

ug/l

0.35

Angina pectoris

170

856

1.32

2.94

1.8

1.6

12.52

8.64

ug/l

0.74

152

789

Disorders of optic nerve and visual pathways

250

1.73

2.91

1.2

1.6

7.58

8.34

ug/l

0.17

221

Common variable immunodeficiency

5.51

2.89

1.6

1.3

8.19

6.72

ug/l

—

Benign neoplasm: Skin of lower limb, including hip

2.45

2.89

2.0

1.3

9.09

6.38

ug/l

0.42

Sequelae of other and unspecified effects of external causes

6.81

2.88

3.7

1.2

9.43

6.47

ug/l

—

Other/unspecified seropositive rheumatoid arthritis

624

1.45

2.88

1.6

1.5

8.44

9.45

ug/l

0.16

564

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

616

1.45

2.87

1.6

1.5

8.52

8.21

ug/l

0.05

556

Bacterial pneumonia, not elsewhere classified

128

827

1.36

2.85

2.1

1.5

13.81

8.36

ug/l

1.16

118

765

Personal history of other diseases and conditions

366

1.58

2.83

1.5

1.6

6.07

6.48

ug/l

0.20

332

Sensorineural hearing loss

252

1349

1.25

2.81

1.5

1.6

7.92

9.77

ug/l

1.05

237

1231

Postmenopausal bleeding

300

1.49

2.81

1.6

1.5

7.54

8.42

ug/l

0.35

272

Lactose intolerance, other/unspecified

2.41

2.81

1.6

1.5

6.85

5.89

ug/l

0.33

Type 2 diabetes, definitions combined, including avohilmo

383

1852

1.20

2.80

1.4

1.6

8.39

8.14

ug/l

0.10

344

1695

Anterior Iridocyclitis

513

1.49

2.80

1.5

7.65

7.92

ug/l

0.09

463

Open wound of abdomen, lower back and pelvis

2.48

2.79

1.2

1.5

16.71

9.11

ug/l

0.28

Injury of muscle and tendon at shoulder and upper arm level

118

863

1.37

2.79

1.4

1.6

6.60

9.80

ug/l

1.95

111

793

Bipolar affective disorders

546

1.47

2.79

1.2

1.5

5.89

6.76

ug/l

0.46

490

Other respiratory diseases principally affecting the interstitium

330

1.61

2.79

1.6

1.5

9.38

10.88

ug/l

0.19

296

Conductive and sensorineural hearing loss

271

1458

1.23

2.78

1.6

9.08

9.53

ug/l

0.11

255

1334

IBD patients in KELA-register

687

1.42

2.78

1.5

7.70

7.32

ug/l

0.09

623

Car occupant injured in other and unspecified transport accidents

581

1.45

2.74

1.3

1.5

8.42

7.25

ug/l

0.17

523

Statin medication

287

1317

1.23

2.73

1.3

1.6

8.20

7.90

ug/l

0.10

256

1212

Keratitis

136

1021

1.33

2.73

1.5

9.60

7.72

ug/l

0.36

124

933

Melanocytic naevi of scalp and neck

2.45

2.72

1.2

1.3

5.69

6.23

ug/l

0.22

Hydrocele

174

1.84

2.71

2.0

1.4

20.07

8.79

ug/l

0.76

162

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

182

889

1.29

2.71

1.2

1.5

5.15

6.20

ug/l

1.37

162

804

Other obstetric conditions, not elsewhere classified

186

913

1.29

2.70

1.2

1.5

5.13

6.31

ug/l

1.64

164

827

Psoriasis

105

759

1.39

2.68

1.4

1.6

7.23

7.75

ug/l

0.18

697

COPD

114

675

1.37

2.68

1.6

1.7

14.37

10.70

ug/l

0.42

102

616

Intestinal malabsorption

112

2.07

2.67

1.8

1.6

8.92

7.35

ug/l

0.43

100

Acute tubulo-interstitial nephritis

238

1620

1.24

2.66

1.7

1.5

12.04

8.09

ug/l

0.92

211

1485

Poisoning by drugs, medicaments and biological substances

107

778

1.38

2.65

1.4

1.5

9.93

6.94

ug/l

0.66

102

702

Pregnancy hypertension

197

1393

1.27

2.64

1.5

7.74

7.04

ug/l

0.22

180

1260

Vasomotor rhinitis (mode)

176

1.83

2.63

1.6

9.99

8.58

ug/l

0.18

156

Contact with sharp object, undetermined intent

2.48

2.62

1.9

1.4

6.86

6.61

ug/l

0.05

Other endocrine disorders

141

1.91

2.62

3.7

1.7

24.10

6.59

ug/l

0.66

125

Protozoal diseases, including avohilmo

2.48

2.62

1.1

1.3

5.68

5.85

ug/l

0.07

Problems related to social environment

2.48

2.62

1.3

5.93

6.00

ug/l

0.03

Other and unspecified mononeuropathies of lower limb

2.57

2.62

1.1

1.7

6.14

8.25

ug/l

0.55

Post-traumatic wound infection, not elsewhere classified

2.56

2.62

1.0

1.3

22.81

6.26

ug/l

0.53

Disorders of lens

222

1100

1.25

2.59

1.5

1.6

10.10

8.93

ug/l

0.26

205

1011

Cystic fibrosis

7.47

2.58

3.4

1.3

13.44

7.54

ug/l

—

Immunodeficiency associated with other major defects

7.45

2.58

12.0

1.3

78.22

8.26

ug/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

3.08

2.57

1.3

8.57

6.34

ug/l

0.60

Hypertrophy of breast in women and men

606

1.42

2.56

1.4

1.5

18.35

7.61

ug/l

0.56

548

Primary coxarthrosis, bilateral

581

1.43

2.56

1.5

1.7

7.73

10.48

ug/l

0.99

531

Endometriosis ASRM stages 3,4

707

1.39

2.56

1.4

1.5

6.82

6.79

ug/l

0.01

634

Early onset COPD

475

1.48

2.54

1.6

10.04

10.87

ug/l

0.11

433

Disorders of mineral metabolism

186

1.78

2.52

1.1

1.5

7.67

7.96

ug/l

0.07

168

Ulcerative colitis

692

1.39

2.52

1.5

8.60

7.74

ug/l

0.15

628

STROKE

194

1033

1.27

2.51

1.4

1.6

9.80

8.60

ug/l

0.21

181

955

Gestational [pregnancy-induced] hypertension

126

947

1.33

2.51

1.4

5.96

6.84

ug/l

0.56

114

866

Peritonsillar abscess

485

1.47

2.50

1.3

1.4

6.37

6.95

ug/l

0.34

450

Epilepsy

710

1.38

2.45

1.4

1.6

7.01

8.05

ug/l

0.45

651

Chronic nephritic syndrome

2.25

2.44

1.8

1.2

9.52

6.33

ug/l

0.92

Acute epiglottitis

3.16

2.44

1.4

1.3

7.74

5.87

ug/l

—

Bacterial pneumoniae

132

880

1.32

2.44

2.1

1.5

16.64

8.29

ug/l

1.40

122

814

Early complications of trauma

2.09

2.43

1.1

1.4

17.52

8.62

ug/l

0.38

!Aliquae complicationes praecoces traumatis

2.09

2.43

1.1

1.4

17.52

8.62

ug/l

0.38

Benign neoplasm: Rectum, anus and anal canal

431

1.49

2.43

1.8

1.6

10.34

11.02

ug/l

0.07

389

Other chronic obstructive pulmonary disease

107

644

1.36

2.42

1.5

1.7

10.12

10.69

ug/l

0.10

587

Effects of foreign body entering through natural orifice

672

1.39

2.42

1.5

9.27

7.68

ug/l

0.16

609

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

530

1.44

2.42

1.2

1.5

9.87

6.89

ug/l

0.44

475

Respiratory insufficiency

2.08

2.40

1.3

1.6

11.33

8.52

ug/l

0.27

Other (seronegative) rheumatoid arthritis, wide

432

1.49

2.40

1.4

1.6

7.21

9.08

ug/l

0.56

389

Hypotension

281

1.60

2.38

1.3

1.6

18.88

11.73

ug/l

0.34

250

Benign neoplasm: Rectum

369

1.52

2.36

1.9

1.5

11.08

8.82

ug/l

0.27

333

Testicular dysfunction

2.16

2.35

2.9

1.5

9.85

8.40

ug/l

0.19

Fracture at wrist and hand level

133

1017

1.31

2.34

1.5

6.17

7.53

ug/l

1.32

123

919

Suicide or other Intentional self-harm

104

770

1.35

2.34

1.3

1.5

9.58

7.10

ug/l

0.50

700

Sequelae of injuries of upper limb

244

1.65

2.34

1.4

1.5

5.71

8.95

ug/l

1.93

216

Cystic kidney disease

2.32

1.0

1.5

7.19

7.98

ug/l

0.17

Retention of urine

573

1.37

2.31

1.4

1.5

7.81

9.58

ug/l

0.79

520

Necrosis of pulp, including avohilmo

244

1991

1.21

2.28

1.6

1.5

11.59

7.68

ug/l

0.64

231

1812

Chondromalacia

2.24

2.28

1.1

1.6

5.05

6.15

ug/l

0.85

Erythema nodosum

2.47

2.28

2.8

1.4

9.33

6.48

ug/l

0.33

Type 2 diabetes, strict (exclude DM1)

375

1860

1.17

2.28

1.5

1.6

8.44

8.19

ug/l

0.10

339

1700

Acute nephritic syndrome

2.77

2.28

1.2

8.59

6.56

ug/l

0.42

Anxious personality disorder

2.58

2.28

2.3

1.5

19.29

6.82

ug/l

0.78

Heart failure and coronary heart disease

106

550

1.35

2.26

1.5

1.6

21.00

9.22

ug/l

0.77

512

L01XX Other antineoplastic agents

106

1.99

2.25

2.6

1.5

10.61

10.41

ug/l

0.02

Prolapse and hernia of ovary and fallopian tube

2.73

2.24

2.1

1.7

6.55

11.20

ug/l

0.42

Endometriosis diagnosis and infertility diagnosis occurring together

358

1.51

2.24

1.2

1.4

5.41

6.41

ug/l

0.64

323

Myocardial infarction, without ST-elevation

660

1.35

2.24

1.3

1.6

11.90

10.87

ug/l

0.09

608

Superficial injury of head

639

1.38

2.23

1.7

1.6

8.84

7.85

ug/l

0.15

581

Injury of muscle and tendon at wrist and hand level

334

1.53

2.23

1.8

1.6

5.64

8.57

ug/l

2.17

296

Pediculosis, acariasis and other infestations, including avohilmo

556

1.41

2.23

1.4

1.5

6.52

7.04

ug/l

0.27

500

Disorders of adrenal gland, other and/or unspecified

5.66

2.22

1.4

1.2

4.52

7.58

ug/l

—

Blepharochalasis

632

1.38

2.22

1.8

1.6

21.54

8.83

ug/l

0.68

579

Other specified disorders of muscle

2.42

2.20

1.5

1.4

10.55

5.83

ug/l

0.44

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

449

1.45

2.20

1.4

1.5

5.78

8.13

ug/l

2.41

404

Unspecified haematuria

124

772

1.31

2.20

1.7

1.6

14.74

9.59

ug/l

0.37

116

703

Presence of cardiac and vascular implants and grafts

116

645

1.32

2.19

1.6

19.06

9.34

ug/l

0.72

110

590

Type 2 diabetes, definitions combined

373

1856

1.17

2.19

1.5

1.6

8.44

8.20

ug/l

0.09

337

1696

Coxarthrosis, primary

178

1185

1.25

2.17

1.5

1.6

7.71

10.05

ug/l

1.65

163

1086

Colonic or urogenital fistula

712

1.35

2.17

1.4

1.5

8.98

9.02

ug/l

0.01

647

Inflammatory bowel disease, strict (require KELA)

721

1.35

2.16

1.5

7.70

7.13

ug/l

0.14

656

Disorders of eyelid in diseases classified elsewhere

2.22

2.11

1.5

5.55

7.20

ug/l

0.43

Lesion of lateral popliteal nerve

2.01

2.10

1.1

1.7

8.38

10.20

ug/l

0.22

Other keratitis

299

1.54

2.10

1.2

1.5

10.55

8.05

ug/l

0.19

266

Type 2 diabetes

393

1962

1.16

2.09

1.4

1.6

8.55

8.07

ug/l

0.21

356

1797

Adult-onset Still disease

5.12

2.08

1.8

1.3

3.28

8.97

ug/l

—

Other and specified injuries of hip and thigh

2.58

2.08

1.3

1.2

10.86

6.83

ug/l

0.27

Other and unspecified disorders of adult personality and behaviour

5.08

2.08

1.2

1.5

3.78

10.33

ug/l

—

Granuloma annulare

2.93

2.08

1.7

1.5

6.90

6.02

ug/l

—

Senile cataract

191

940

1.24

2.06

1.4

1.6

10.43

8.78

ug/l

0.34

174

865

Heart failure,strict

143

783

1.28

2.06

1.5

1.6

16.58

8.76

ug/l

0.68

130

718

Complications predominantly related to the puerperium

121

936

1.30

2.06

1.7

1.4

9.07

6.73

ug/l

0.66

114

845

Use of pramipexole

506

1.41

2.06

1.8

1.7

8.70

10.71

ug/l

0.29

459

Molar incisor enamel hypoplasia, with caries

3.52

2.05

2.4

2.2

7.84

6.92

ug/l

—

Polymyalgia rheumatica

230

1.61

2.04

1.2

1.5

19.48

9.27

ug/l

0.44

208

Need for other prophylactic measures

132

1.83

2.03

2.2

1.8

7.64

10.03

ug/l

0.34

118

Biomechanical lesions, not elsewhere classified

111

1.90

2.01

1.3

1.5

8.35

7.66

ug/l

0.11

Portal vein thrombosis

2.84

2.00

1.1

1.3

4.69

6.49

ug/l

—

Other psoriatic arthropathies

263

1.56

2.00

1.4

1.5

7.90

8.54

ug/l

0.16

236

Type 2 diabetes, wide definition

268

1421

1.19

1.99

1.6

11.01

8.96

ug/l

0.55

247

1309

Congenital malformations of the urinary system

141

1.78

1.97

1.0

1.6

6.04

6.99

ug/l

0.46

125

Alzheimer’s disease, strict definition

314

0.56

1.95

1.6

1.4

7.15

12.08

ug/l

1.00

282

Hypertrophy of breast

554

1.38

1.95

1.4

1.5

6.88

7.17

ug/l

0.11

502

Right ventricular outflow tract obstruction

3.80

1.94

1.5

1.8

4.25

6.19

ug/l

—

Non-invasive ventilation

521

1.36

1.94

1.4

1.6

10.16

7.13

ug/l

0.98

483

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

346

1.48

1.93

1.5

11.71

8.42

ug/l

0.37

308

Atrial fibrillation and flutter

481

1.33

1.93

1.9

1.6

9.54

9.25

ug/l

0.05

442

Non-rheumatic valve diseases

135

759

1.27

1.91

2.0

1.5

9.88

8.13

ug/l

0.44

123

704

Otitis media, unspecified

349

1.46

1.91

1.5

1.6

5.18

6.58

ug/l

0.93

313

Cardiomyopathy, other and unspecified

150

1.74

1.90

2.0

1.3

11.29

7.15

ug/l

0.56

135

Alzheimer’s disease (Late onset)

275

0.54

1.90

1.7

1.4

7.78

12.33

ug/l

0.75

250

Glucosamine medication

125

783

1.28

1.87

1.5

1.6

13.08

9.89

ug/l

0.40

116

717

Calcific aortic valvular stenosis, diagnosis (helper)

431

1.41

1.87

1.9

1.5

12.74

11.14

ug/l

0.14

396

Operations 2 for CAVS

431

1.41

1.87

1.9

1.5

12.74

11.14

ug/l

0.14

396

Erosion of teeth , including avohilmo

116

906

1.28

1.86

1.3

1.5

5.65

6.87

ug/l

1.50

108

827

Calcific aortic valvular stenosis, operated

432

1.40

1.85

1.9

1.5

12.74

11.13

ug/l

0.14

397

Calcific aortic valvular stenosis

432

1.40

1.85

1.9

1.5

12.74

11.13

ug/l

0.14

397

Other (not insulin) diabetes medications

377

1924

1.15

1.84

1.4

1.6

8.36

8.23

ug/l

0.05

343

1761

Protozoal diseases

2.22

1.84

1.2

1.3

4.98

5.84

ug/l

0.47

Small fibre neuropathy

2.22

1.84

1.3

5.45

6.34

ug/l

0.33

Pulmonary heart disease, diseases of pulmonary circulation

672

1.33

1.83

1.4

1.6

9.34

10.10

ug/l

0.17

610

Bus occupant injured in other and unspecified transport accidents

4.22

1.83

2.4

1.3

11.44

7.95

ug/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

567

1.32

1.81

1.3

1.5

21.31

9.07

ug/l

0.75

520

Other specified and unspecified disorders of eye and adnexa

1.96

1.80

1.2

1.4

4.17

6.17

ug/l

1.04

Calcific aortic valvular stenosis, including rheumatic fever

434

1.40

1.80

1.9

1.5

12.74

11.09

ug/l

0.15

399

Malignant neoplasm of respiratory system and intrathoracic organs

271

0.55

1.78

2.1

1.3

17.34

7.36

ug/l

0.60

244

Carcinoma in situ of other and unspecified genital organs

2.36

1.78

1.4

5.87

5.57

ug/l

0.08

Hyperaldosteronism

2.18

1.78

2.2

1.5

8.93

6.58

ug/l

0.39

Spontaneous abortion

203

1131

1.20

1.76

1.5

6.75

6.93

ug/l

0.10

186

1030

Psoriatic arthropathies, ICD10

272

1.51

1.76

1.4

1.5

7.90

8.62

ug/l

0.19

244

Valvular heart disease excluding rheumatic fever

135

769

1.25

1.76

2.0

1.5

9.88

8.12

ug/l

0.44

123

714

Torsion of ovary, ovarian pedicle and fallopian tube

2.15

1.72

2.4

1.4

8.33

7.95

ug/l

0.03

Exfoliative dermatitis

3.88

1.72

1.2

1.3

4.38

6.96

ug/l

—

Other metabolic disorders

381

1.42

1.71

1.5

1.6

10.83

8.18

ug/l

0.26

340

Disorder of the sleep-wake schedule

2.31

1.71

1.4

4.23

6.04

ug/l

1.33

Occupational exposure to risk-factors

2.01

1.70

1.3

1.4

5.73

7.93

ug/l

0.75

Chronic periodontitis, including avohilmo

373

2088

1.14

1.66

1.7

1.5

10.49

8.18

ug/l

0.82

331

1925

Other hearing loss

511

1.35

1.65

1.4

1.7

7.89

11.59

ug/l

1.02

462

Other sexually transmitted chlamydial diseases

220

1.55

1.65

1.4

1.3

5.45

6.17

ug/l

0.28

197

Diffuse large B-cell lymphoma, including Hilmo

1.98

1.64

1.1

1.4

6.69

7.88

ug/l

0.34

Diffuse large B-cell lymphoma, helper endpoint

1.98

1.64

1.1

1.4

6.69

7.88

ug/l

0.34

Diffuse large B-cell lymphoma

1.98

1.64

1.1

1.4

6.69

7.88

ug/l

0.34

Viral pneumonia (unknown virus, not influenza)

150

1.67

1.63

3.0

1.7

28.34

9.18

ug/l

0.70

134

Periodontitis

373

2089

1.14

1.63

1.7

1.5

10.49

8.17

ug/l

0.82

331

1926

Inhalation and ingestion of other objects causing obstruction of respiratory tract

3.62

1.62

3.8

1.6

3.56

8.88

ug/l

—

Cholangitis (primary sclerosing, PSC)

120

1.76

1.62

2.1

1.6

10.85

8.73

ug/l

0.29

104

Pleural plaque with presence of asbestos

1.84

1.61

1.1

1.3

7.56

9.03

ug/l

0.44

Other infective otitis externa

143

1.68

1.61

1.3

1.6

6.96

9.19

ug/l

0.59

126

Orchitis and epididymitis

151

1.66

1.59

1.6

1.3

37.07

8.97

ug/l

0.47

137

Drug-induced osteoporosis with pathological fracture

2.35

1.59

1.8

1.2

8.53

6.38

ug/l

—

Benign neoplasm: Skin of ear and external auricular canal

1.96

1.59

1.4

1.2

6.31

7.73

ug/l

0.28

Arthropathic psoriasis

279

1.47

1.58

1.4

1.5

7.90

8.21

ug/l

0.08

253

Cytomegaloviral disease, including avohilmo

2.21

1.57

2.2

1.3

9.93

6.75

ug/l

0.36

Rare circulating lymphoid malignancy, including Hilmo

2.21

1.57

1.0

1.5

6.20

8.77

ug/l

0.58

Substance use, excluding alcohol

594

1.32

1.57

1.6

1.5

10.82

7.30

ug/l

0.57

536

Nephrotic syndrome

2.04

1.54

1.6

1.5

11.51

6.37

ug/l

0.70

Abrasion of teeth

133

1084

1.23

1.54

1.4

1.5

6.74

7.90

ug/l

0.32

121

987

Single delivery by forceps and vacuum extractor

415

0.72

1.51

1.2

1.5

7.27

6.64

ug/l

0.11

376

Postprocedural endocrine and metabolic disorders, not elsewhere classified

349

1.41

1.51

1.5

11.39

7.61

ug/l

0.35

311

Focal epilepsy, mode (most common among epilepsy diagnosis)

468

1.35

1.50

1.4

1.5

6.89

9.65

ug/l

0.78

419

Pulmonary embolism

616

1.30

1.49

1.5

1.6

8.44

10.42

ug/l

0.60

557

Pulmonary heart disease

616

1.30

1.49

1.5

1.6

8.44

10.42

ug/l

0.60

556

Pneumonia due to other infectious organisms, not elsewhere classified

1.95

1.49

1.6

1.4

4.41

7.61

ug/l

1.43

Idiopathic thrombocytopenic purpura

2.01

1.49

1.4

1.3

12.47

5.95

ug/l

1.66

Injuries to the elbow and forearm

282

2106

1.15

1.49

1.6

8.71

8.33

ug/l

0.10

261

1925

Hypertensive heart and/or renal disease

328

1.36

1.48

1.6

10.06

10.02

ug/l

0.01

306

Thoracic aortic aneurysm

259

1.47

1.3

1.6

5.44

10.26

ug/l

3.10

235

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

303

0.62

1.46

2.3

1.3

19.84

7.26

ug/l

0.92

272

Myopia

420

1.36

1.45

2.2

1.5

11.25

7.02

ug/l

0.31

377

Hypoplasia of dental enamel, prenatal , including avohilmo

3.18

1.45

1.6

2.5

3.90

5.82

ug/l

—

Burns and corrosions

386

1.38

1.44

2.1

1.6

8.05

8.00

ug/l

0.01

348

Testicular hypofunction

1.93

1.44

2.5

1.3

9.22

8.75

ug/l

0.04

Injury of muscle and tendon at ankle and foot level

2.05

1.44

1.1

1.3

6.87

6.15

ug/l

0.23

Heart failure and bmi 25plus

463

1.28

1.43

1.4

1.6

17.19

9.09

ug/l

0.44

427

False labour

156

804

1.21

1.43

1.6

1.5

6.79

7.04

ug/l

0.10

141

723

Heart failure, strict

153

883

1.20

1.42

1.5

1.6

17.56

9.05

ug/l

0.81

138

811

Preterm labour and delivery

105

843

1.25

1.42

1.6

1.5

6.80

7.20

ug/l

0.17

100

763

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.27

1.40

1.4

1.3

7.31

5.75

ug/l

—

Myocardial infarction

127

725

1.22

1.40

1.4

1.6

11.62

8.58

ug/l

0.45

116

670

COPD, hospital admission 2, with asthma infections

535

1.29

1.39

1.3

1.6

9.25

11.59

ug/l

0.43

496

Postpartum haemorrhage due to anatomy

389

1.37

1.39

1.1

1.4

4.38

6.38

ug/l

3.22

352

Oesophagitis

1.78

1.39

1.2

1.5

8.35

8.08

ug/l

0.03

Other disorders of binocular movement

1.95

1.38

2.4

1.2

7.34

5.93

ug/l

0.16

Alcoholic liver disease

198

0.50

1.38

1.2

1.6

11.56

9.18

ug/l

—

178

Family history of other conditions

2.21

1.37

4.8

1.4

28.79

6.24

ug/l

—

Coronary atherosclerosis

183

977

1.18

1.37

1.6

10.75

8.39

ug/l

0.51

166

904

All-cause Heart Failure

150

869

1.20

1.36

1.5

1.6

17.89

8.98

ug/l

0.84

135

799

Focal epilepsy, strict definition

494

1.32

1.36

1.4

1.5

6.36

9.36

ug/l

0.95

444

Lung diseases due to external agents

231

1.47

1.36

1.2

1.5

13.61

12.76

ug/l

0.04

206

Thyrotoxicosis, other and/or unspecified

556

1.30

1.35

1.9

1.6

14.30

8.21

ug/l

0.52

502

Pre-eclampsia or eclampsia

725

1.26

1.34

1.4

6.78

6.52

ug/l

0.14

658

Malignant neoplasm of bronchus and lung

228

0.59

1.33

1.5

1.3

17.06

7.19

ug/l

0.50

205

Vascular dementia (subcortical)

0.00

1.32

0.0

1.2

—

9.15

—

Primary open-angle glaucoma

562

1.28

1.31

1.5

1.6

10.30

10.50

ug/l

0.02

516

Diabetes mellitus

404

2093

1.11

1.31

1.4

1.6

9.11

7.90

ug/l

0.59

366

1919

Focal epilepsy

541

1.30

1.31

1.4

1.5

6.53

9.20

ug/l

0.90

486

Other specific arthropathies, wide

2.10

1.30

1.9

1.8

5.84

9.56

ug/l

—

Disorders of acoustic nerve

2.10

1.30

1.2

1.4

9.52

7.44

ug/l

—

Hypoplasia of dental enamel

2.51

1.30

2.7

2.2

4.30

6.33

ug/l

—

Substance abuse, excluding more controls

181

1292

1.17

1.28

1.6

1.5

8.65

8.10

ug/l

0.14

163

1175

Persons encountering health services in circumstances related to reproduction

226

1314

1.15

1.28

1.9

1.5

8.32

7.33

ug/l

0.36

208

1201

Peripheral artery disease

101

645

1.24

1.27

1.3

1.6

20.07

9.65

ug/l

0.65

592

Neuromuscular dysfunction of bladder

202

1.49

1.27

1.1

1.6

20.80

9.07

ug/l

0.35

179

Diabetes, varying definitions

401

2091

1.11

1.25

1.4

1.6

9.13

7.90

ug/l

0.61

363

1917

Vitiligo

2.24

1.24

1.0

1.4

4.76

7.35

ug/l

—

Dysplasia of cervi uteri

506

1.25

1.24

1.4

6.50

6.93

ug/l

0.12

449

1.98

1.22

1.6

1.2

3.91

4.85

ug/l

1.15

Polycystic kidney disease

1.97

1.22

1.0

1.5

7.07

8.54

ug/l

0.29

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

108

1.67

1.22

2.6

1.8

17.43

8.40

ug/l

0.51

Urethritis and urethral syndrome

2.05

1.22

2.0

1.2

6.50

6.39

ug/l

—

Unspecified lump in breast

434

1.32

1.21

2.0

1.5

6.72

7.69

ug/l

0.46

391

144

0.49

1.20

1.1

1.6

7.26

14.91

ug/l

—

128

Schizophrenia or delusion

931

0.79

1.20

1.5

7.47

7.42

ug/l

0.01

849

Muscle strain

1.84

1.19

1.6

1.4

4.87

6.07

ug/l

0.86

Diabetes medication

406

2142

1.11

1.19

1.4

1.6

8.97

7.98

ug/l

0.47

367

1967

Malignant neoplasm of eye and adnexa, including Hilmo

2.32

1.19

1.3

8.22

7.56

ug/l

—

Pneumocystosis, including avohilmo

2.12

1.18

1.3

1.2

4.01

6.01

ug/l

—

Pneumocystosis

2.12

1.18

1.3

1.2

4.01

6.01

ug/l

—

Other congenital malformations of the digestive system

116

1.63

1.18

2.2

1.4

7.06

6.02

ug/l

0.52

103

Cytomegalovirus infection, IBD co-morbidity

2.01

1.16

2.3

1.2

10.70

6.24

ug/l

—

Cytomegaloviral disease

2.01

1.16

2.3

1.3

10.70

6.75

ug/l

—

Non-ischemic cardiomyopathy

493

1.26

1.14

1.5

8.12

8.30

ug/l

0.05

461

Other abnormal products of conception

159

891

1.17

1.14

1.5

7.63

6.83

ug/l

0.19

140

805

Other and unspecified mononeuropathies of upper limb

1.85

1.13

1.7

1.4

4.53

6.16

ug/l

0.96

Oral leukoplakia, including avohilmo

1.91

1.12

2.5

1.3

6.91

6.27

ug/l

0.20

Malignant neoplasm of tonsil and base of tongue, including Hilmo

2.01

1.12

1.3

1.4

5.71

6.20

ug/l

—

Female infertility, tubal origin

127

1.58

1.11

1.1

1.4

5.71

7.27

ug/l

0.59

115

Corneal scars and opacities

1.97

1.11

1.3

1.2

4.06

6.28

ug/l

—

Other congenital malformations of the digestive system, including avohilmo

134

1.56

1.11

2.3

1.4

6.73

6.67

ug/l

0.02

119

Somnolence, stupor and coma

1.79

1.11

2.2

1.5

5.51

8.13

ug/l

0.73

Dipeptidyl peptidase 4 (DPP-4) inhibitors

157

1055

1.17

1.10

1.4

1.7

8.70

9.93

ug/l

0.55

146

971

Excessive earwax

207

1643

1.14

1.10

1.6

12.14

8.73

ug/l

0.64

194

1509

Schizophrenia, schizotypal and delusional disorders

931

0.80

1.10

1.5

7.43

7.42

ug/l

0.00

849

Periapical abscess

164

1415

1.16

1.10

1.6

1.5

8.01

8.31

ug/l

0.13

150

1295

Malignant neoplasm of bronchus and lung, including Hilmo

265

0.66

1.10

1.8

1.3

19.86

7.21

ug/l

0.81

238

Dementia in Alzheimer disease

205

0.61

1.10

2.1

1.4

10.33

12.93

ug/l

0.23

182

Thyrotoxicosis

718

1.23

1.09

1.8

1.6

13.49

8.03

ug/l

0.58

649

Congenital stenosis of pulmonary valve

2.41

1.09

1.6

1.5

3.88

6.64

ug/l

—

Vestibular neuronitis

193

1.45

1.09

2.1

1.6

14.55

9.50

ug/l

0.54

167

Embedded and impacted teeth

129

885

1.18

1.08

1.4

1.5

7.28

6.44

ug/l

0.18

119

791

Anomalies of dental arch relationship, including avohilmo

641

1.23

1.08

1.2

1.5

4.61

6.77

ug/l

4.28

581

Maternal care for known or suspected malpresentation of fetus

569

1.22

1.07

1.7

1.4

6.59

5.92

ug/l

0.41

513

Medical abortion

263

1264

1.13

1.07

1.8

1.5

9.37

6.99

ug/l

0.84

241

1151

Other and unspecified corneal deformities and disorders

1.76

1.07

1.2

1.5

18.08

7.18

ug/l

0.35

Biguanides

348

1898

1.11

1.06

1.3

1.6

7.70

8.53

ug/l

0.57

316

1736

Other strabismus

684

1.22

1.04

1.7

1.5

6.32

6.83

ug/l

0.30

620

Pre-eclampsia

678

1.23

1.04

1.4

1.5

6.56

6.46

ug/l

0.05

615

Benign neoplasm: Vulva

1.97

1.04

1.3

1.8

6.61

8.72

ug/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

606

1.24

1.03

2.0

1.5

15.49

7.85

ug/l

0.71

549

Hirsutism in women

1.84

1.03

1.3

1.6

4.51

6.09

ug/l

1.59

Localized scleroderma [morphea]

2.07

1.03

1.6

1.2

6.70

6.67

ug/l

—

Malignant neoplasm of tonsil and base of tongue

2.07

1.03

1.3

1.4

6.13

6.46

ug/l

—

Systemic sclerosis (FG)

1.92

1.02

1.1

2.0

6.50

9.37

ug/l

—

Other disorders of prostate

1.92

1.02

1.0

1.4

5.19

9.39

ug/l

—

Hypertensive Heart Disease

297

1.30

1.02

1.5

1.6

9.86

10.00

ug/l

0.02

276

Impacted teeth

707

1.20

1.01

1.5

8.03

6.47

ug/l

0.27

624

Nontraumatic intracranial haemmorrhage

369

0.70

1.01

1.5

1.6

20.98

11.36

ug/l

0.31

332

Fasciculation

2.01

1.00

1.1

1.2

54.27

7.30

ug/l

—

Other lack of coordination

2.01

1.00

1.7

1.3

6.87

6.72

ug/l

—

Other disorders of amniotic fluid and membranes

527

1.25

1.00

1.5

1.4

6.16

6.20

ug/l

0.01

475

Other maternal disorders predominantly related to pregnancy

247

1377

1.12

0.99

1.5

7.70

7.19

ug/l

0.18

222

1250

Other/unspecified cytomegaloviral diseases

1.85

0.99

2.4

1.3

11.17

6.75

ug/l

—

Pemphigoid

1.84

0.98

1.2

4.58

6.54

ug/l

—

Organic, including symptomatic, mental disorders

823

0.84

0.98

1.5

9.54

10.49

ug/l

0.19

753

Brain glioblastoma

0.00

0.98

0.0

1.3

—

8.02

—

Secondary malignant neoplasm of respiratory and digestive organs

0.00

0.98

0.0

1.6

—

9.23

—

Embolic stroke with flimmer

0.00

0.98

0.0

1.1

—

9.55

—

Labour and delivery complicated by fetal stress [distress]

697

0.83

0.97

1.6

1.4

5.51

6.30

ug/l

0.63

622

Use of antiglaucoma preparations and miotics

124

1.54

0.96

2.3

1.4

15.72

10.21

ug/l

0.26

106

Secondary right heart disease

1.74

0.96

1.8

1.5

15.43

9.23

ug/l

0.41

Mucosal proctocolitis

354

1.30

0.95

1.3

1.5

7.87

7.71

ug/l

0.04

315

Ulcerative colitis (strict definition, all Crohn cases excluded)

408

1.28

0.94

1.3

1.5

7.07

7.63

ug/l

0.18

365

COPD, hospital admissions 3, with asthma pneumonia sepsis

387

1.26

0.93

1.4

1.5

10.80

10.97

ug/l

0.02

354

Autoimmune thyroiditis

1.74

0.92

1.3

1.6

6.47

7.57

ug/l

—

Erosion and ectropion of cervix uteri

1.83

0.92

1.4

1.3

7.01

6.75

ug/l

—

Thiazolidinediones

209

1.39

0.92

2.1

1.6

9.76

8.05

ug/l

0.42

188

Disorder of external ear, unspecified

1.67

0.91

1.2

1.3

5.92

5.95

ug/l

0.01

COPD (mode)

381

1.25

0.91

1.3

1.7

10.34

8.65

ug/l

0.28

360

Intracerebral haemorrhage

194

0.62

0.88

1.2

1.6

5.25

9.81

ug/l

1.67

171

Chronic periodontitis, complicated

178

1534

1.13

0.88

1.6

1.5

12.59

9.11

ug/l

0.64

157

1415

Undefined dementia

117

0.55

0.88

2.1

1.5

9.17

17.46

ug/l

—

104

Unspecified dementia

116

0.54

0.88

2.1

1.4

9.17

16.63

ug/l

—

Injury of nerves at wrist and hand level

1.61

0.87

2.1

1.3

6.66

8.10

ug/l

0.24

Retinal detachments and breaks

805

1.18

0.85

1.8

1.5

13.05

9.78

ug/l

0.50

734

Other and unspecified psoriasis

137

1.46

0.84

1.5

1.6

9.00

8.46

ug/l

0.10

124

Maternal care for known or suspected abnormality of pelvic organs

121

705

1.16

0.83

1.4

5.89

6.80

ug/l

0.58

106

635

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

114

0.53

0.82

1.2

1.4

3.98

7.71

ug/l

—

SLE (Finngen)

1.61

0.81

1.2

1.6

4.41

7.90

ug/l

1.51

Acute alcohol intoxication, ICD10

535

1.22

0.81

1.6

1.5

11.84

7.61

ug/l

0.57

485

Hypersomnia

1.83

0.79

1.2

1.1

6.18

5.80

ug/l

—

Other disorders of iris and ciliary body

1.67

0.79

1.0

1.2

6.44

10.20

ug/l

—

Other chronic obstructive pulmonary disease, including avohilmo

139

1002

1.14

0.78

1.4

1.6

9.29

10.14

ug/l

0.20

124

920

Male infertility

1.53

0.78

1.7

1.6

16.88

8.68

ug/l

0.36

Presbycusis

188

1.37

0.77

1.6

8.78

13.88

ug/l

0.54

170

Strabismus

803

1.17

0.76

1.7

1.5

7.27

7.00

ug/l

0.09

734

Benign neoplasm: Skin of lip

1.77

0.76

1.3

1.2

4.48

6.24

ug/l

—

Varicose veins

179

1208

1.12

0.76

1.6

9.29

9.50

ug/l

0.05

163

1111

Pre-eclampsia or poor fetal growth

133

1166

1.14

0.75

1.5

1.4

6.83

6.86

ug/l

0.02

122

1054

Malignant neoplasm of kidney, except renal pelvis

124

1.45

0.75

1.7

1.3

8.00

7.47

ug/l

0.10

107

Labour and delivery complicated by umbilical cord complications

158

1.40

0.74

1.1

1.5

3.62

6.86

ug/l

3.24

140

Lung cancer and mesothelioma

246

0.72

0.74

1.8

1.5

19.86

8.92

ug/l

0.66

231

Pyoderma

1.85

0.73

1.0

1.2

5.77

6.64

ug/l

—

Anomalies of pupillary function

1.64

0.73

1.0

1.4

4.98

6.42

ug/l

—

Malignant neoplasm of urinary organs

133

1.43

0.73

1.7

1.3

7.92

7.57

ug/l

0.07

116

Contraceptive management

164

1022

1.12

0.73

1.8

1.5

8.45

7.35

ug/l

0.21

153

931

Other and unspecified bullous disorders

2.01

0.73

1.0

1.3

4.72

7.40

ug/l

—

Fracture of shoulder and upper arm

108

939

1.15

0.72

2.0

1.6

10.79

8.69

ug/l

0.38

100

858

Benign neoplasm: Cranial nerves

1.61

0.72

1.2

1.3

9.52

5.79

ug/l

—

Hypertrichosis

1.62

0.72

1.3

1.5

4.51

6.11

ug/l

1.76

Mental disorders, not otherwise specified

255

1.30

0.71

1.5

1.4

7.30

7.06

ug/l

0.05

229

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

516

1.20

0.71

1.3

1.6

6.75

7.73

ug/l

0.44

464

Other sexually transmitted chlamydial diseases, including avohilmo

371

1.24

0.71

1.3

1.4

5.37

5.66

ug/l

0.14

333

Papilloedema, unspecified

1.56

0.70

1.0

1.3

6.02

6.61

ug/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

144

0.62

0.69

1.3

1.4

5.88

7.27

ug/l

—

129

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

237

1681

1.09

0.69

1.6

1.5

11.03

7.70

ug/l

0.66

215

1529

Hyperplasia of prostate

362

1.18

0.68

1.5

1.6

18.91

8.71

ug/l

0.49

335

Benign neoplasm: Adrenal gland

178

1.35

0.68

1.2

1.6

5.60

8.24

ug/l

1.66

157

HSIL lesion of the vulva

1.67

0.68

1.3

1.6

5.97

5.93

ug/l

—

1.60

0.68

1.5

5.80

6.05

ug/l

0.08

Other specified disorders of external ear

1.60

0.68

2.4

1.3

8.43

8.59

ug/l

0.02

Molar incisor enamel hypoplasia

121

1.43

0.68

2.1

1.6

5.36

5.43

ug/l

0.02

111

Later onset COPD, excluding more controls

222

1.27

0.68

1.2

1.5

10.29

9.15

ug/l

0.15

211

Myocardial infarction, strict

109

674

1.14

0.68

1.4

1.6

12.32

8.60

ug/l

0.48

624

COPD, hospital admissions

106

780

1.14

0.68

1.5

1.6

10.15

10.64

ug/l

0.08

714

COPD, early/later onset

107

785

1.14

0.67

1.5

1.6

10.12

10.67

ug/l

0.10

719

Benign neoplasm of other and unspecified female genital organs

102

1.47

0.67

1.2

1.7

5.83

8.44

ug/l

0.90

Kela-code for severe mental illness

1090

0.87

0.67

1.4

1.5

7.36

7.27

ug/l

0.03

999

Other localized connective tissue disorders

1.63

0.67

1.6

1.2

6.70

6.63

ug/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

136

1.40

0.66

1.7

1.3

45.95

7.53

ug/l

0.49

119

Inflammation of lacrimal passages (chronic)

1.79

0.66

3.4

1.1

6.34

6.55

ug/l

—

Chronic hepatitis, not elsewhere classified

1.52

0.66

1.1

1.6

5.06

8.06

ug/l

1.24

Arterial embolism and thrombosis

1.51

0.66

1.4

1.6

11.96

10.60

ug/l

0.09

Alcohol use disorder, Swedish definition

139

1410

0.90

0.64

1.6

1.5

8.15

8.78

ug/l

0.22

127

1291

Alcohol withdrawal state with delirium

129

0.62

0.63

2.6

1.7

25.46

9.46

ug/l

—

114

All dysplastic lesions of the cervix uteri

1034

0.87

0.62

1.4

6.35

6.65

ug/l

0.09

937

Use of galantamine

101

0.59

0.62

1.5

1.3

4.52

17.81

ug/l

—

Aortic aneurysm

362

1.22

0.62

1.4

1.6

7.26

9.84

ug/l

1.21

332

Antenatal screening

536

0.87

0.61

1.9

1.4

13.02

6.05

ug/l

0.72

490

Supervision of high-risk pregnancy

504

1.15

0.61

1.5

1.4

6.26

6.10

ug/l

0.09

460

Atrial fibrillation and flutter with reimbursement

347

1.18

0.61

2.0

1.7

9.65

8.49

ug/l

0.23

325

Gingival hyperplasia

1.48

0.60

1.3

5.38

6.14

ug/l

0.42

Intercostal neuropathy

0.00

0.60

0.0

1.3

—

7.98

—

Assault by unspecified means

1.57

0.60

1.0

1.4

4.89

10.58

ug/l

—

Alcohol use disorder, ICD-based

1121

0.88

0.59

1.5

1.6

7.36

9.14

ug/l

0.69

1028

Malignant neoplasm of stomach, including Hilmo

1.53

0.59

1.4

36.86

8.01

ug/l

0.41

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

473

1.19

0.58

1.3

1.5

6.83

7.74

ug/l

0.35

424

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.58

0.0

1.2

—

8.23

—

Use of biperiden

114

0.61

0.58

2.3

1.5

15.77

9.00

ug/l

—

Other salmonella infections, including avohilmo

1.43

0.56

1.3

1.5

7.46

6.09

ug/l

0.32

Complications of labour and delivery

251

1290

1.08

0.56

1.6

1.5

7.75

7.37

ug/l

0.13

231

1168

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

0.58

0.56

2.8

1.4

14.56

7.60

ug/l

—

Other congenital malformations of circulatory system

1.54

0.55

1.3

1.2

5.06

5.99

ug/l

—

Pregnancy examination and test

403

1.15

0.55

1.3

5.17

5.88

ug/l

0.56

365

Convergence insufficiency and excess

1.59

0.54

2.2

1.3

3.58

6.37

ug/l

—

Hyphaema and other vascular disorders of iris and ciliary body

1.58

0.54

1.0

1.1

7.32

6.37

ug/l

—

Contact with nonpowered hand tool

1.43

0.53

2.5

1.4

8.35

8.65

ug/l

0.04

Other aneurysm

1.43

0.53

1.9

1.6

11.33

10.54

ug/l

0.07

Single spontaneous delivery

127

744

0.90

0.53

1.6

1.5

7.09

7.74

ug/l

0.22

110

673

Mental and behavioural disorders due to alcohol, excluding acute intoxication

108

1193

0.90

0.52

1.6

7.63

8.96

ug/l

0.50

1101

Non-small cell lung cancer, including Hilmo

202

0.74

0.52

1.7

1.3

21.68

7.32

ug/l

0.66

182

Leiomyoma of uterus

230

1195

1.08

0.52

1.4

1.5

7.58

7.78

ug/l

0.08

210

1087

Systemic sclerosis

1.41

0.51

1.1

1.6

6.50

7.81

ug/l

—

Lesion of sciatic nerve

1.41

0.51

1.3

1.5

9.13

11.02

ug/l

—

COPD related to multimorbidity

650

1.13

0.51

1.4

1.6

10.38

11.22

ug/l

0.13

598

Mental and behavioural disorders due to opioids

109

1.38

0.51

2.9

1.4

24.48

7.96

ug/l

0.58

Disorders of choroid and retina

247

1609

1.07

0.51

1.5

1.6

11.38

9.01

ug/l

0.58

228

1476

Burn and corrosion of trunk

1.39

0.50

2.8

1.3

5.17

6.70

ug/l

—

Benign neoplasm of brain and other parts of central nervous system

144

1.32

0.50

2.2

1.6

13.06

7.17

ug/l

0.58

127

COPD, hospital admissions 1, only main diagnosis

557

1.14

0.50

1.4

1.5

9.90

11.20

ug/l

0.20

515

Other and unspecified nonorganic psychotic disorders

596

0.85

0.50

1.6

1.5

6.30

7.10

ug/l

0.34

538

Distal bite

117

1.36

0.50

1.1

1.6

4.76

5.85

ug/l

1.04

104

Renal cell carcinoma of kidney

1.47

0.50

1.5

1.4

6.37

10.05

ug/l

—

Pyogenic arthritis

127

1.34

0.49

1.3

1.6

7.62

8.59

ug/l

0.24

113

Polycystic ovarian syndrome, broad definition

436

1.17

0.49

1.2

1.4

4.96

6.12

ug/l

1.35

388

Whooping cough, including avohilmo

1.53

0.48

1.1

1.7

3.91

6.54

ug/l

—

Coxarthrosis, primary, with hip surgery

114

955

1.11

0.48

1.5

1.6

7.93

10.38

ug/l

1.28

102

881

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

1.45

0.48

1.0

1.3

6.03

6.04

ug/l

0.00

Ulcerative colitis (strict definition, require KELA)

493

1.16

0.48

1.3

1.6

6.75

7.75

ug/l

0.41

442

Nonischemic cardiomyopathy

199

1.26

0.47

1.5

1.4

9.96

8.50

ug/l

0.20

183

Normotensive glaucoma

154

0.71

0.47

1.5

1.4

8.47

9.32

ug/l

0.19

132

166

1563

0.92

0.46

1.6

1.5

9.62

8.45

ug/l

0.30

151

1435

Rubella [German measles]

1.43

0.46

4.3

1.4

11.59

7.52

ug/l

—

Rubella [German measles], including avohilmo

1.43

0.46

4.3

1.4

11.59

7.52

ug/l

—

Follicular lymphoma, hilmo

1.43

0.45

2.8

1.5

14.46

7.69

ug/l

0.76

Complications associated with artificial fertilization

1.40

0.45

1.1

1.4

6.83

6.87

ug/l

—

Open wound of head

166

1441

1.08

0.44

1.7

1.6

8.92

8.32

ug/l

0.18

149

1325

Alzheimer’s disease (Late onset), excluding more controls

143

0.77

0.43

1.7

1.9

7.25

13.62

ug/l

1.43

132

Alzheimer’s disease (Atypical or mixed)

125

0.71

0.43

2.7

1.5

19.29

16.64

ug/l

—

108

Other salmonella infections

1.41

0.43

1.4

8.35

6.21

ug/l

0.42

HSIL lesion of the vagina

1.62

0.43

1.2

1.3

3.68

6.56

ug/l

—

Intermittent heterotropia

173

0.75

0.42

1.6

1.5

3.83

7.27

ug/l

1.95

152

Injuries involving multiple body regions

1.38

0.42

1.8

1.4

24.66

6.06

ug/l

0.50

Other and unspecified disease of Bartholin gland

1.41

0.42

1.9

9.40

9.67

ug/l

—

Certain zoonotic bacterial diseases, including avohilmo

1.41

0.42

1.7

1.2

8.00

6.16

ug/l

—

Systemic lupus erythematosus

1.36

0.41

1.2

1.7

4.41

7.86

ug/l

1.74

Medical treatment for female infertility

852

1.11

0.41

1.5

1.4

5.97

6.29

ug/l

0.17

772

Other, unspecified and serous retinal detachments

1.38

0.41

1.6

1.4

11.50

6.66

ug/l

—

Unspecified mental disorder

115

1256

0.91

0.41

1.4

1.5

7.69

7.09

ug/l

0.23

105

1148

Slow fetal growth and fetal malnutrition

0.00

0.41

0.0

2.7

—

4.85

—

Deep bite that required surgery

1.52

0.41

1.0

1.2

5.04

6.62

ug/l

—

Pregnancy with abortive outcome

261

1279

1.06

0.41

1.7

1.5

9.05

6.95

ug/l

0.62

236

1165

Malignant neoplasm of bone and articular cartilage, including Hilmo

1.52

0.41

1.2

1.6

6.66

8.44

ug/l

—

Bacterial sepsis of newborn

0.00

0.41

0.0

2.3

—

4.88

—

Psoas tendinitis

0.00

0.41

0.0

1.7

—

8.38

—

Congenital dislocation of hip, unilateral

0.00

0.41

0.0

1.6

—

6.98

—

Cleft lip and cleft lip and palate

0.00

0.41

0.0

1.7

—

8.44

—

Other and unspecified nail disorders

1.36

0.41

1.1

1.7

5.92

8.25

ug/l

—

Later onset COPD

349

0.85

0.41

1.2

1.6

10.29

12.84

ug/l

0.30

320

Meckel's diverticulum

0.00

0.41

0.0

1.2

—

6.93

—

Subarachnoid haemorrhage

194

0.77

0.40

1.9

1.5

32.33

8.51

ug/l

0.49

174

ILD, hospital admissions 3, with pneumonia sepsis

141

1.28

0.40

1.8

1.6

8.23

9.55

ug/l

0.30

123

Other encephalitis

1.31

0.39

1.5

1.4

5.85

6.66

ug/l

—

Inflammation of lacrimal passages (acute and unspecified)

1.43

0.39

1.0

1.3

4.04

6.30

ug/l

—

Congenital deformities of feet

1.41

0.39

1.3

1.4

4.25

6.29

ug/l

—

Other congenital malformations of male genital organs

0.00

0.39

0.0

1.6

—

6.48

—

Other congenital malformations of male genital organs, including avohilmo

0.00

0.39

0.0

1.6

—

6.48

—

Vitamin B12 deficiency anaemia

187

1.23

0.38

1.0

1.6

5.76

13.53

ug/l

1.05

164

All dysplastic lesions of the vulva

124

1.29

0.38

3.9

1.9

25.59

8.83

ug/l

0.40

107

All dysplastic lesions of the vagina

1.38

0.38

7.1

1.6

36.89

7.48

ug/l

0.50

Thyroiditis, unspecified

1.39

0.38

2.4

1.3

4.50

5.53

ug/l

—

Perichondritis of external ear

1.39

0.38

1.0

1.2

5.94

6.24

ug/l

—

Systemic sclerosis, icd10

1.35

0.38

1.1

1.6

6.50

7.84

ug/l

—

Benign neoplasm of other and unspecified sites

1.35

0.38

1.0

1.6

4.37

7.71

ug/l

—

Chorioretinal inflammation

1.33

0.37

1.0

1.4

5.40

6.16

ug/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

212

1467

1.06

0.37

1.6

1.5

11.31

6.89

ug/l

0.87

192

1329

Cardiomyopathy, Hypertrophic obstructive

1.35

0.37

1.2

1.1

6.98

6.35

ug/l

—

Erectile dysfunction

116

1.29

0.37

1.4

1.7

8.23

9.52

ug/l

0.23

104

Chronic Coagulation defects

1.39

0.37

1.1

1.5

7.30

6.53

ug/l

—

Dilated cardiomyopathy

216

1.20

0.36

1.5

1.6

10.09

9.73

ug/l

0.04

195

Abnormal findings on antenatal screening of mother

328

1.16

0.36

1.6

1.3

15.50

5.26

ug/l

0.83

293

Open wound of shoulder and upper arm

1.43

0.35

1.2

1.3

7.70

10.44

ug/l

—

Agoraphobia

1.32

0.35

1.0

1.5

3.90

7.55

ug/l

1.11

Inguinal hernia

164

1018

1.07

0.35

1.5

1.6

7.00

9.56

ug/l

1.44

152

936

Disorders of tooth development and eruption

366

1.13

0.35

1.3

1.7

21.21

7.45

ug/l

0.40

343

Otosclerosis

153

1.24

0.35

1.2

1.5

6.84

8.33

ug/l

0.47

133

Tooth agenesis EXCLUDE clefts and syndromes

125

0.72

0.35

1.0

1.4

4.37

7.11

ug/l

—

115

Obstructed labour due to malposition and malpresentation of fetus

815

1.09

0.34

1.8

1.4

8.35

6.75

ug/l

0.28

735

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

298

0.84

0.34

1.3

1.5

16.82

8.90

ug/l

0.68

271

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

329

1862

1.05

0.34

1.5

1.6

9.89

8.19

ug/l

0.77

303

1708

LSIL lesion of the vagina

1.37

0.34

9.8

1.3

57.17

6.40

ug/l

—

conjunctival degenerations and deposits

1.37

0.34

1.3

1.7

5.08

9.04

ug/l

—

Acute alcohol intoxication

642

1.11

0.34

1.6

1.5

11.43

9.84

ug/l

0.17

582

Unspecified maternal hypertension

1.34

0.34

1.0

1.6

5.08

6.48

ug/l

—

LSIL lesion of the vulva

1.32

0.34

4.8

2.0

32.28

8.94

ug/l

0.42

Alcohol-induced chronic pancreatitis

118

1.27

0.33

1.2

1.5

16.88

9.32

ug/l

0.70

104

Benign neoplasm: Short bones of upper limb

1.31

0.33

1.3

1.4

7.82

6.06

ug/l

—

L02BB Anti-androgens

132

0.76

0.32

1.0

1.5

7.09

15.48

ug/l

—

119

Malignant neoplasm of rectum

143

0.77

0.32

1.0

1.3

4.79

7.93

ug/l

1.76

125

Diabetes, insulin treatment (Kela reimbursement)

347

1978

1.04

0.32

1.5

1.6

10.91

8.21

ug/l

1.03

320

1810

158

1498

0.94

0.31

1.6

1.5

9.87

8.54

ug/l

0.33

143

1375

Certolizumab pegol

1.32

0.31

1.1

1.3

9.59

6.41

ug/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

1.32

0.31

1.3

5.26

6.36

ug/l

—

Fracture of skull and facial bones

561

1.11

0.30

2.0

1.6

9.85

7.71

ug/l

0.50

510

Inflammatory disease of cervix uteri

142

0.77

0.30

1.4

1.5

6.40

8.08

ug/l

0.57

124

Retinal vascular occlusion

193

1.19

0.30

1.9

1.5

18.63

12.60

ug/l

0.34

172

Hypoplasia of dental enamel , including avohilmo

115

1.26

0.30

2.2

1.6

5.82

5.40

ug/l

0.09

106

Malignant neoplasm of breast, including Hilmo

116

798

0.93

0.30

1.5

1.4

7.25

7.28

ug/l

0.01

108

714

Fall involving bed

1.30

0.30

2.6

1.5

8.90

7.40

ug/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

116

798

0.93

0.30

1.5

1.4

7.25

7.28

ug/l

0.01

108

714

Persons with potential health hazards related to communicable diseases

151

1407

1.06

0.30

1.4

1.5

6.64

6.48

ug/l

0.09

128

1293

Benign neoplasm: Conjunctiva

1.34

0.30

1.1

1.4

5.41

6.35

ug/l

—

Impotence

1.29

0.30

1.3

13.05

8.33

ug/l

0.30

Periodontal disease, other/unspecified

1.25

0.29

1.3

1.7

5.43

7.87

ug/l

—

Corneal ulcer

515

1.11

0.29

1.5

11.35

7.80

ug/l

0.38

463

Other specified/unspecified disorders of bone/cartilage

1.23

0.29

1.1

1.4

28.60

5.87

ug/l

—

Drug-induced neutropenia

162

0.80

0.28

1.7

1.5

12.07

8.41

ug/l

0.31

143

Foreign body entering into or through eye or natural orifice

195

1.18

0.28

1.7

1.6

6.14

8.43

ug/l

0.79

176

Sixth [abducent] nerve palsy

1.29

0.28

3.0

1.3

18.10

7.70

ug/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.77

0.28

2.7

1.8

19.29

13.33

ug/l

—

Benign neoplasm of middle ear and respiratory system

149

1.21

0.27

1.3

1.6

9.57

9.20

ug/l

0.04

133

Malignant neoplasm of breast

114

786

0.93

0.27

1.5

1.4

7.27

7.31

ug/l

0.01

105

704

Cerebrovascular diseases

201

1325

1.05

0.27

1.3

1.6

9.32

9.34

ug/l

0.00

189

1217

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

119

0.75

0.27

1.2

1.7

5.73

8.78

ug/l

—

107

Retinal vascular disorders

196

1.17

0.27

1.9

1.5

18.63

12.52

ug/l

0.35

175

Other disorders of bone density and structure

1.21

0.26

1.9

1.2

48.49

5.95

ug/l

—

Dislocation, sprain and strain of joint and ligaments of hip

1.21

0.26

1.0

1.4

4.97

7.68

ug/l

—

Malignant neoplasm of stomach

1.21

0.26

1.3

1.4

4.49

8.08

ug/l

—

Nonspecific lymphadenitis

150

1.20

0.26

1.6

1.7

6.24

8.21

ug/l

0.55

134

Traumatic amputation of wrist and hand

1.19

0.26

1.8

1.4

8.10

10.34

ug/l

—

Mental and behavioural disorders due to alcohol

138

1391

0.94

0.26

1.6

1.5

9.60

8.77

ug/l

0.17

124

1278

Malignant neoplasm of breast, HER2-negative

114

784

0.94

0.26

1.5

1.4

7.27

7.31

ug/l

0.01

105

703

Injury of eye and orbit

386

1.11

0.26

1.3

1.6

6.10

8.10

ug/l

1.20

347

Abnormal findings on diagnostic imaging of central nervous system

132

1.21

0.25

1.3

1.5

6.77

7.22

ug/l

0.11

113

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.25

0.25

1.4

1.2

9.86

7.66

ug/l

—

Oesophageal varices

1.23

0.25

1.3

1.5

12.76

7.31

ug/l

—

Use of selegiline

1.23

0.25

2.7

1.4

8.01

8.30

ug/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

110

1142

0.94

0.25

1.9

1.4

9.72

6.86

ug/l

0.43

103

1028

Postpartum hemorraghe, parous women as controls

109

855

1.07

0.25

1.3

1.5

5.38

7.12

ug/l

1.17

775

Long labour

826

0.93

0.25

1.3

1.4

7.66

6.98

ug/l

0.11

743

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.20

0.25

1.1

1.6

5.83

8.05

ug/l

—

Malignant neoplasm of eye, brain and central nervous system

1.20

0.25

1.1

1.6

4.09

10.32

ug/l

—

Benign neoplasm: Liver

1.19

0.24

1.3

1.4

8.84

6.48

ug/l

—

Premature separation of placenta [abruptio placentae]

0.74

0.24

1.0

1.5

5.95

7.14

ug/l

—

Neovascular glaucoma

1.28

0.24

2.7

1.4

10.50

6.60

ug/l

—

Maternal care for other known or suspected fetal problems

115

679

1.06

0.23

1.5

1.4

6.06

6.55

ug/l

0.27

110

611

Traumatic subdural haemorrhage

177

1.16

0.23

2.7

1.7

16.82

11.88

ug/l

0.21

164

Pregnancy, childbirth and the puerperium

100

489

1.07

0.23

1.5

1.4

5.83

6.32

ug/l

0.29

444

Toxic effect of ethanol

1.24

0.23

1.0

1.5

7.44

7.89

ug/l

0.06

Certain zoonotic bacterial diseases

1.25

0.22

1.2

8.28

6.68

ug/l

—

Stroke, including SAH

145

1093

0.95

0.22

1.3

1.6

10.19

9.18

ug/l

0.15

136

1004

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

125

1.20

0.22

1.4

1.6

7.25

8.83

ug/l

0.27

107

Nystagmus and other irregular eye movements

1.22

0.22

1.0

1.3

6.90

6.35

ug/l

—

Tularaemia, including avohilmo

1.22

0.22

1.2

10.22

6.92

ug/l

—

Amputation of thigh

1.22

0.22

1.0

1.1

4.70

7.13

ug/l

—

Chronic inflammatory disorders of orbit

0.00

0.21

0.0

1.2

—

8.05

—

Congenital malformations of lung, including avohilmo

0.00

0.21

0.0

1.6

—

5.42

—

Cleft lip

0.00

0.21

0.0

2.0

—

9.35

—

Drug-induced dystonia

0.00

0.21

0.0

1.5

—

9.70

—

Myotonic dystrophy (Steinert)

0.00

0.21

0.0

1.5

—

7.73

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.19

0.21

3.8

1.6

14.80

6.55

ug/l

—

Unspecified multiple injuries

0.00

0.21

0.0

1.4

—

8.61

—

Maxillary hypoplasia

0.00

0.21

0.0

1.3

—

7.54

—

Abnormal findings in nipple discharge synovial fluid wound secretions

1.19

0.21

1.0

1.3

7.98

7.27

ug/l

—

Down's syndrome

0.00

0.21

0.0

2.0

—

6.65

—

Other disorders following mastoidectomy

0.00

0.21

0.0

1.0

—

5.31

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

0.21

0.0

1.7

—

7.75

—

Other cestode infections, including avohilmo

0.00

0.21

0.0

1.5

—

7.88

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.21

0.0

1.3

—

6.75

—

Congenital hydrocephalus

0.00

0.21

0.0

1.4

—

9.68

—

Open wounds involving multiple body regions

0.00

0.21

0.0

1.1

—

6.16

—

Acidosis

1.19

0.21

1.2

1.3

8.18

7.04

ug/l

—

Other dermatomyositis

0.00

0.21

0.0

1.5

—

9.23

—

Deaf mutism, not elsewhere classified

0.00

0.21

0.0

1.2

—

6.97

—

Wilms' tumor, including Hilmo

0.00

0.21

0.0

2.0

—

8.23

—

Unspecified protein-energy malnutrition

0.00

0.21

0.0

1.4

—

8.55

—

Follicular adenocarcinoma of thyroid gland

0.00

0.21

0.0

1.6

—

8.96

—

Schizophrenia or delusion, excluding more controls

782

0.93

0.21

1.5

7.47

7.22

ug/l

0.07

710

Malignant neoplasm of adrenal gland

0.00

0.21

0.0

2.2

—

8.38

—

Ectopic testis

0.00

0.21

0.0

1.9

—

6.96

—

Abnormality of red blood cells

0.00

0.21

0.0

1.3

—

7.15

—

Other retinal disorders

176

1280

1.04

0.21

1.4

1.6

11.93

9.01

ug/l

0.55

163

1178

Infective bursitis

1.16

0.21

1.6

1.3

6.04

6.15

ug/l

—

Postpartum care and examination

360

1.08

0.21

1.5

1.3

6.26

5.74

ug/l

0.30

326

Exposure to ignition of highly flammable material

0.00

0.21

0.0

1.1

—

6.28

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

0.00

0.21

0.0

1.0

—

5.44

—

Other diseases of gallbladder

1.24

0.21

1.4

1.6

6.90

9.60

ug/l

0.62

Glaucoma secondary to other eye disorders

1.25

0.20

2.7

1.4

10.50

7.43

ug/l

—

Cleft lip and palate

0.00

0.20

0.0

1.4

—

8.71

—

Moderate visual impairment, binocular

1.25

0.20

1.0

1.4

6.50

7.08

ug/l

—

Dissection of aorta

1.25

0.20

1.0

1.3

4.57

9.25

ug/l

—

Oesophageal obstruction

1.25

0.20

1.0

1.2

6.08

8.03

ug/l

—

Congenital malformations of breast

1.23

0.20

1.2

5.08

5.67

ug/l

—

Loose body in joint

1.23

0.20

1.7

9.00

9.98

ug/l

—

Abdominal aortic aneurysm (AAA)

112

0.80

0.20

1.3

11.53

9.35

ug/l

—

104

Obstructed labour due to maternal pelvic abnormality

432

1.09

0.20

1.9

1.5

8.81

8.24

ug/l

0.12

396

Drug-induced cataract

1.15

0.19

1.2

1.5

5.15

6.38

ug/l

—

Pedestrian injured in collision with car, pick-up truck or van

1.15

0.19

1.2

1.3

3.53

6.88

ug/l

—

Congenital malformations of breast, including avohilmo

1.13

0.18

1.2

5.08

5.84

ug/l

—

Combinations of oral blood glucose lowering drugs

622

0.93

0.18

2.1

1.7

11.50

11.17

ug/l

0.03

574

Non-small cell lung cancer

130

0.84

0.17

1.0

1.3

5.27

7.80

ug/l

1.59

115

Status epilepticus

1.13

0.17

1.1

1.6

5.17

7.48

ug/l

—

Benign neoplasm: Liver/bile ducts

1.22

0.17

1.3

1.4

8.37

6.37

ug/l

—

Peripheral retinal degeneration

0.72

0.17

1.4

1.7

5.60

8.45

ug/l

—

Ill-defined and unknown causes of mortality

152

0.85

0.16

2.1

1.5

7.12

14.59

ug/l

0.74

135

Congenital malformations of great arteries

0.71

0.16

1.4

1.8

4.52

6.54

ug/l

—

Polyhydramnios

173

0.87

0.16

1.3

1.4

6.35

6.15

ug/l

0.05

149

Superficial injuries involving multiple body regions

1.18

0.16

2.0

1.4

7.53

6.52

ug/l

—

Encephalitis

1.18

0.16

1.5

1.4

5.85

6.45

ug/l

—

Diabetes mellitus in pregnancy

138

913

0.96

0.16

1.3

1.5

5.37

6.81

ug/l

1.35

125

826

Clear cell adenocarcinoma of kidney

1.13

0.16

2.3

1.4

10.05

7.96

ug/l

—

Disorders of speech understanding and production

118

1.16

0.16

1.6

1.5

5.25

5.55

ug/l

0.16

109

Use of interferon beta-1a

1.10

0.15

1.1

1.5

3.35

6.41

ug/l

—

Bicuspidal aortic valve syndrome

0.78

0.15

1.0

1.5

5.80

8.77

ug/l

—

Anisometropia and aniseikonia

0.77

0.15

1.3

1.7

4.52

8.01

ug/l

—

Other and unspecified vascular occlusions

149

1.14

0.15

2.1

1.4

22.31

8.63

ug/l

0.83

130

Diabetic retinopathy, excluding more controls

375

1.06

0.15

1.6

1.4

21.56

7.97

ug/l

1.29

343

Mental and behavioural disorders due to psychoactive substance use

188

1667

1.03

0.15

1.6

1.5

8.85

8.56

ug/l

0.07

168

1530

Substance abuse

181

1627

1.03

0.15

1.6

1.5

8.65

8.40

ug/l

0.06

163

1495

Other ill-defined and unspecified causes of mortality

140

0.86

0.15

2.1

1.5

7.19

15.48

ug/l

0.75

123

Insulin, intermediate and long-acting

152

1415

1.04

0.15

1.3

1.6

12.37

8.79

ug/l

0.62

143

1297

Postpartum hemorraghe, all women as controls

109

1019

1.04

0.15

1.3

1.4

5.38

6.81

ug/l

0.96

923

Pneumonia due to Streptococcus pneumoniae

0.80

0.14

1.0

1.6

58.94

11.30

ug/l

—

Burn and corrosion of wrist and hand

1.18

0.14

2.8

1.5

13.26

6.50

ug/l

0.39

Malignant neoplasm of brain, including Hilmo

0.83

0.13

1.5

1.6

5.93

9.52

ug/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

110

0.82

0.13

1.0

1.5

5.36

10.23

ug/l

—

Postpartum haemorrhage

109

866

1.04

0.12

1.3

1.4

5.38

6.92

ug/l

0.99

775

Malignant neoplasm of breast, HER-positive

636

1.04

0.12

1.4

7.32

7.75

ug/l

0.13

568

Acute appendicitis, with complications

487

0.94

0.11

2.2

1.5

12.32

7.91

ug/l

0.38

438

Fracture of forearm

183

1601

1.03

0.11

1.7

1.5

10.15

8.18

ug/l

0.45

168

1457

Delivery

138

750

0.97

0.11

1.6

6.97

7.71

ug/l

0.28

119

679

Graves disease, strict definition

302

0.93

0.11

1.0

1.5

15.54

7.81

ug/l

0.35

268

Malignant neoplasm of breast, ER-positive, including Hilmo

637

1.04

0.11

1.4

7.32

7.75

ug/l

0.13

569

Single delivery by caesarean section

475

0.96

0.11

1.4

1.5

5.81

6.62

ug/l

0.34

432

Medicines for HER+ breast cancer

101

972

0.97

0.10

1.3

1.6

7.07

8.73

ug/l

0.86

890

Diabetic retinopathy

496

1.04

0.10

1.6

1.4

19.60

8.26

ug/l

1.29

459

Paranoid personality disorder

1.14

0.10

1.6

1.2

5.92

6.21

ug/l

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

1.09

0.09

1.0

1.4

8.06

6.99

ug/l

—

Exposure to other specified electric current

1.09

0.09

1.2

1.3

6.02

6.42

ug/l

—

Benign neoplasm: Anus and anal canal

1.07

0.08

1.0

1.3

4.77

6.41

ug/l

—

Benign neoplasm: Larynx

1.05

0.08

1.8

1.4

16.70

7.82

ug/l

—

Isolated proteinuria

1.03

0.08

2.8

1.2

12.67

7.25

ug/l

—

Carcinoma in situ, bladder

1.03

0.08

4.7

1.2

36.02

10.01

ug/l

—

Alzheimer’s disease (Early onset)

0.79

0.08

1.0

1.4

3.96

8.19

ug/l

—

Endocarditis

1.08

0.08

2.7

1.2

15.74

8.21

ug/l

—

Ovarian hyperstimulation (induction)

1.05

0.08

1.1

1.5

6.83

5.86

ug/l

—

Other diseases of spinal cord

1.05

0.08

1.4

7.46

5.99

ug/l

—

Congenital malformations of uterus and cervix

1.03

0.08

1.1

1.5

4.53

5.72

ug/l

—

Use of ropinirole

1.03

0.08

1.7

1.4

5.57

8.91

ug/l

—

Cirrhosis of liver, NAS

1.12

0.07

1.4

1.6

9.46

8.67

ug/l

0.14

Degeneration of macula and posterior pole

105

790

1.03

0.07

1.4

1.6

8.80

10.39

ug/l

0.48

725

Delivery, wide proxy

117

606

1.02

0.07

1.6

1.5

7.08

7.29

ug/l

0.06

103

546

Benign neoplasm: Rectosigmoid junction

0.87

0.07

1.1

1.5

4.81

8.10

ug/l

—

Benign neoplasm of thyroid gland

0.85

0.07

1.3

1.6

5.51

7.84

ug/l

—

Abscess of Bartholin gland

0.84

0.07

1.6

1.5

4.26

6.96

ug/l

—

Tuberculosis

0.82

0.07

2.6

1.5

6.86

20.82

ug/l

—

Non-small cell lung cancer, adenocarcinoma

1.07

0.07

1.0

1.3

5.36

7.57

ug/l

—

Car occupant injured in noncollision transport accident

1.06

0.07

1.2

1.4

27.59

8.57

ug/l

—

Carcinoma in situ of other and unspecified digestive organs

1.05

0.07

1.0

1.6

3.88

8.23

ug/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.03

0.07

2.9

1.5

8.83

5.67

ug/l

—

Systemic lupus erythematosus, unspecified

1.02

0.07

1.2

1.4

4.08

6.01

ug/l

—

Insulin, fast-acting or short human

983

0.98

0.07

1.3

1.6

14.65

8.82

ug/l

0.66

902

Cholesteatoma of middle ear

0.88

0.06

1.1

1.5

5.44

10.13

ug/l

—

Other acquired deformities of musculoskeletal system and connective tissue

0.86

0.06

1.6

1.5

7.58

6.64

ug/l

—

Amblyopia ex anopsia

102

0.88

0.06

1.4

6.67

6.08

ug/l

—

Paralytic strabismus

142

0.92

0.06

2.2

1.5

13.29

7.36

ug/l

0.45

126

Tuberculosis, IBD comorbidity

101

0.89

0.06

2.2

1.4

6.99

18.03

ug/l

—

Tuberculosis, wide

104

0.87

0.06

2.2

1.4

6.99

18.12

ug/l

—

Tuberculosis, wide, including avohilmo

104

0.87

0.06

2.2

1.4

6.99

18.12

ug/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

173

1543

1.02

0.06

1.2

1.6

11.57

8.66

ug/l

0.55

161

1413

Papillary adenocarcinoma of thyroid gland

121

0.91

0.06

1.8

1.3

7.63

6.40

ug/l

0.38

104

Pedal cyclist injured in transport accident

672

1.03

0.05

1.4

1.5

8.17

7.33

ug/l

0.22

610

Gestational diabetes (for exclusion)

165

1117

1.02

0.05

1.6

1.5

7.02

7.01

ug/l

0.00

149

1008

Thyrotoxicosis with diffuse goitre

395

0.96

0.05

1.1

1.6

12.39

8.41

ug/l

0.25

353

Spasmodic torticollis

1.11

0.05

1.6

6.21

7.30

ug/l

—

L02BG Aromatase inhibitors

801

1.02

0.05

1.4

1.6

7.56

8.40

ug/l

0.30

731

Ischaemic Stroke, excluding all haemorrhages

127

919

1.02

0.05

1.2

1.6

10.64

9.19

ug/l

0.19

118

841

Cardiodefibrillation

683

1.02

0.04

1.8

1.5

17.21

10.43

ug/l

0.56

632

Focal brain injury

109

0.92

0.04

2.7

1.6

18.21

9.59

ug/l

—

100

Insulin, fast-acting

974

0.98

0.03

1.2

1.6

14.65

8.93

ug/l

0.64

895

Supervision of normal pregnancy

516

0.98

0.03

1.7

1.4

12.68

6.05

ug/l

0.73

471

Maternal care related to the fetus and amniotic cavity and possible delivery problems

182

1059

1.01

0.02

1.5

6.18

7.57

ug/l

1.07

165

959

Contact with and exposure to communicable diseases

117

1175

0.99

0.02

1.3

1.4

6.61

6.23

ug/l

0.26

1074

Left ventricular outflow tract obstruction, narrow definition

103

1.07

0.02

1.0

1.5

5.41

8.54

ug/l

0.85

Retinal breaks without detachment

397

0.98

0.01

1.4

1.6

13.11

8.89

ug/l

0.30

360

Insulin medication

173

1428

1.00

0.01

1.2

1.6

11.57

8.38

ug/l

0.62

161

1314

Open bite

184

1.03

0.00

1.3

1.6

3.68

6.35

ug/l

3.19

159

Stroke, excluding SAH

138

992

1.00

0.00

1.2

1.7

10.21

9.41

ug/l

0.11

129

907

Endovascular or surgical operations to intracerebral aneurysms

129

1.01

0.00

1.7

1.5

6.45

7.85

ug/l

0.43

113

SLE, strict definition

1.04

0.00

1.2

1.6

4.29

7.39

ug/l

—

SLE, ICD10

1.04

0.00

1.2

1.6

4.29

7.39

ug/l

—

Injury of other and unspecified intrathoracic organs

128

1.02

0.00

2.2

1.5

13.15

9.21

ug/l

0.37

111

Pneumonitis due to solids and liquids

141

0.99

0.00

1.1

1.7

23.30

16.75

ug/l

0.16

124

Maternal care for known or suspected fetal abnormality and damage

546

1.01

0.00

1.4

9.42

6.94

ug/l

0.29

496

Premature rupture of membranes

638

1.00

0.00

1.5

1.4

7.03

6.14

ug/l

0.47

572

Respiratory tuberculosis

0.93

0.00

2.6

1.4

6.86

9.30

ug/l

—

Respiratory tuberculosis, confirmed and not-confirmed

0.93

0.00

2.6

1.4

6.86

9.30

ug/l

—

Unicornuate uterus

0.00

0.0

1.7

—

8.69

—

Transient retinal artery occlusion

0.00

0.0

1.4

—

8.48

—

Dengue fever [classical dengue]

0.00

0.0

1.4

—

7.82

—

Diphtheria, including avohilmo

0.00

0.0

3.4

—

7.52

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.0

1.6

—

8.72

—

Other haemoglobinopathies

0.00

0.0

1.3

—

7.78

—

Chylothorax

0.00

0.0

1.1

—

8.54

—

Carcinoma in situ of colon

0.86

0.00

1.0

1.2

3.28

6.75

ug/l

—

Benign neoplasm: Thymus

0.00

0.0

1.4

—

7.84

—

Schistosomiasis [bilharziasis], including avohilmo

0.00

0.0

1.0

—

4.95

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.0

1.0

—

6.17

—

Aortic stenosis

0.00

0.0

2.0

—

5.53

—

Crushing injury of head

0.00

0.0

1.5

—

7.93

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.2

—

9.96

—

Congenital ptosis, including avohilmo

0.00

0.0

1.9

—

8.40

—

Sunburn

0.00

0.0

1.3

—

6.74

—

Other inherited muscular atrophy

0.00

0.0

1.3

—

7.41

—

Nondiabetic hypoglycaemic coma

0.00

0.0

1.5

—

8.01

—

Primary ovarian failure

1.00

0.00

10.0

1.6

62.38

6.23

ug/l

—

Enterobiasis

0.00

0.0

2.1

—

9.50

—

Aortic stenosis, including avohilmo

0.00

-0.00

0.0

1.9

—

5.81

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.4

—

7.24

—

Motorcycle rider injured in noncollision transport accidents

0.87

-0.00

2.0

1.4

4.82

9.10

ug/l

—

Benign neoplasm: Pancreas

0.93

-0.00

1.2

1.3

6.12

5.90

ug/l

—

Exposure to controlled fire, not in building or structure

0.00

-0.00

0.0

1.3

—

8.57

—

Intentional self-harm by smoke, fire and flames

0.00

-0.00

0.0

1.3

—

9.30

—

Other misadventures during surgical and medical care

0.91

-0.00

1.2

1.3

4.86

6.55

ug/l

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

-0.00

0.0

1.3

—

6.30

—

Biliary cirrhosis, NAS

0.00

-0.00

0.0

1.3

—

8.45

—

Benign neoplasm: Carotid body

0.00

-0.00

0.0

1.1

—

8.27

—

Hereditary spherocytosis

0.00

-0.00

0.0

1.5

—

10.13

—

Benign neoplasm: Respiratory system, unspecified

0.00

-0.00

0.0

1.7

—

10.13

—

Abnormal findings in peritoneal fluid saliva

0.00

-0.00

0.0

1.3

—

6.77

—

Lupus nephritis

0.00

-0.00

0.0

1.0

—

5.61

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

-0.00

0.0

1.4

—

8.22

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.0

—

6.40

—

Haemolytic anaemias

0.96

-0.00

3.0

1.2

34.21

5.92

ug/l

—

Adrenomedullary hyperfunction

0.00

-0.00

0.0

1.0

—

5.74

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.0

—

5.95

—

Drowning to ice

0.00

-0.00

0.0

1.4

—

9.34

—

Discharge of firework

0.00

-0.00

0.0

1.1

—

7.35

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.4

—

8.70

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

-0.00

0.0

1.6

—

8.18

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.4

—

9.06

—

Erectile dysfunction, exclusion

0.00

-0.00

0.0

1.0

—

5.32

—

Cyclic neutropenia

0.00

-0.00

0.0

1.2

—

9.32

—

Malignant neoplasm of thymus

0.00

-0.00

0.0

1.5

—

7.76

—

Neuromyelitis optica

0.00

-0.00

0.0

1.8

—

10.04

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

2.4

—

9.22

—

Hip and thigh

0.00

-0.00

0.0

1.4

—

8.28

—

Traumatic amputation of lower leg

0.00

-0.00

0.0

1.0

—

5.99

—

Digestive system disorders of fetus and newborn

0.00

-0.00

0.0

3.0

—

5.14

—

Traumatic amputation of shoulder and upper arm

0.00

-0.00

0.0

1.0

—

5.62

—

Mental and behavioural disorders due to hallucinogens

0.00

-0.00

0.0

1.6

—

9.89

—

Mucinous and mucinous cystic tumor of rectum

0.00

-0.00

0.0

1.4

—

8.39

—

Ulcerative enterocolitis

1.01

-0.00

1.1

1.4

9.53

6.11

ug/l

—

Physiological and behavioural disorders associated with sexual development and orientation

0.00

-0.00

0.0

1.4

—

7.00

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

2.4

—

9.16

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.4

—

10.06

—

Neuroendocrine tumor and carcinoma of rectum

0.00

-0.00

0.0

1.4

—

8.17

—

Other conjunctival vascular disorders and cysts

0.93

-0.00

1.0

1.3

5.68

6.23

ug/l

—

Other secondary gout

0.00

-0.00

0.0

1.3

—

7.49

—

Tympanosclerosis

0.00

-0.00

0.0

1.2

—

8.38

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

0.00

-0.00

0.0

1.4

—

9.60

—

Congenital malformation of optic disc

0.00

-0.00

0.0

3.0

—

5.94

—

Huntington disease

0.00

-0.00

0.0

1.2

—

9.58

—

Sickle-cell disorders

0.00

-0.00

0.0

1.4

—

7.30

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

2.0

—

5.79

—

Chromophobe cell carcinoma of kidney

0.00

-0.00

0.0

1.0

—

5.44

—

Drug-induced thyroiditis

0.00

-0.00

0.0

1.0

—

6.51

—

Carcinoma in situ of other and unspecified sites

0.92

-0.00

4.7

1.4

36.02

10.41

ug/l

—

Benign neoplasm: Lower jaw bone

0.00

-0.00

0.0

1.6

—

8.10

—

Alzheimer’s disease (Early onset), excluding more controls

0.94

-0.00

1.0

1.6

3.96

9.23

ug/l

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

-0.00

0.0

1.0

—

5.73

—

Alzheimer’s disease (undefined), excluding more controls

0.00

-0.00

0.0

1.0

—

8.92

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.6

—

12.80

—

Ependymoma

0.00

-0.00

0.0

2.0

—

7.24

—

Manic episode

0.99

-0.00

1.0

1.5

4.97

6.17

ug/l

—

Pectus excavatum

0.00

-0.00

0.0

1.2

—

7.90

—

Congenital retinoschisis

0.00

-0.00

0.0

1.2

—

10.08

—

Pectus excavatum, including avohilmo

0.00

-0.00

0.0

1.2

—

7.88

—

Tuberous sclerosis 1

0.00

-0.00

0.0

1.6

—

9.58

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.3

—

7.85

—

Urethral stricture

0.99

-0.00

1.2

1.4

13.58

10.96

ug/l

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

1.4

—

7.18

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

2.0

—

9.32

—

Suppurative otitis media, unspecified

0.91

-0.00

1.0

1.4

4.92

6.05

ug/l

—

Noise effects on inner ear

0.87

-0.00

2.2

1.2

6.70

9.48

ug/l

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

2.1

—

6.61

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

-0.00

0.0

1.0

—

5.91

—

Haemolytic-uraemic syndrome

0.00

-0.00

0.0

1.3

—

7.48

—

Haemophilus septicemia

0.00

-0.00

0.0

1.1

—

8.69

—

ILD medications: acetylcysteine

0.00

-0.00

0.0

1.3

—

6.84

—

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

0.00

-0.00

0.0

1.8

—

11.43

—

Traumatic cerebral oedema

0.00

-0.00

0.0

1.0

—

6.30

—

Small plaque parapsoriasis

0.00

-0.00

0.0

1.0

—

5.46

—

ILD medications: nintedanib

0.00

-0.00

0.0

1.2

—

6.84

—

Burn and corrosion confined to eye and adnexa

1.02

-0.00

1.0

1.5

3.97

10.09

ug/l

—

Noninfective disorders of pinna

0.00

-0.00

0.0

1.0

—

5.98

—

Diphtheria

0.00

-0.00

0.0

3.4

—

7.52

—

Pectus carinatum

0.00

-0.00

0.0

1.2

—

8.74

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.2

—

9.64

—

Turner's syndrome

0.00

-0.00

0.0

1.5

—

6.67

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.2

—

9.48

—

Congenital malformations of lung

0.00

-0.00

0.0

1.7

—

5.77

—

Congenital malposition of the kidney

0.00

-0.00

0.0

2.2

—

9.60

—

Onychogryphosis

0.00

-0.00

0.0

1.6

—

8.90

—

Calcinosis cutis

0.00

-0.00

0.0

1.3

—

7.47

—

Meretoja disease

0.00

-0.00

0.0

1.4

—

8.58

—

Hypertensive encephalopathy

0.00

-0.00

0.0

1.3

—

7.09

—

Pectus carinatum, including avohilmo

0.00

-0.00

0.0

1.2

—

8.74

—

Drug-induced myopathy

0.00

-0.00

0.0

1.2

—

7.02

—

Osteomyelitis of vertebra

0.00

-0.00

0.0

1.3

—

7.51

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.1

—

8.22

—

Cytomegaloviral hepatitis

0.00

-0.00

0.0

1.4

—

9.71

—

Congenital ptosis

0.00

-0.00

0.0

2.2

—

8.98

—

Other specific arthropathies

0.00

-0.00

0.0

1.6

—

8.54

—

Other cestode infections

0.00

-0.00

0.0

1.3

—

7.89

—

Congenital malformations of aortic and mitral valves

0.91

-0.00

1.0

1.5

5.05

8.64

ug/l

—

Haematosalpinx/Haematoma of broad ligament

0.00

-0.00

0.0

2.6

—

3.84

—

Other congenital malformations of integument, including avohilmo

0.00

-0.00

0.0

1.4

—

7.91

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.2

—

8.23

—

Aortic arch syndrome [Takayasu]

0.00

-0.00

0.0

1.4

—

8.04

—

Fetal death of unspecified cause

0.00

-0.00

0.0

1.8

—

8.92

—

Congenital retinoschisis

0.00

-0.00

0.0

1.2

—

10.08

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

2.4

—

8.80

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tryptase [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS